Prof. Rumina Hasan Section of Microbiology Department of Pathology and Laboratory Medicine
SUMMARY: Publication 182 Book Chapters 06 CONTRIBUTIONS TO REPORTS, GUIDELINES AND POLICY DOCUMENTS: 27
RESEARCH GRANTS As Principal Investigator 18 As Co-Investigator 44
PUBLICATION:
Year 2021 01. Antimicrobial resistance and COVID-19: intersections and implications. Gwenan M. Knight, Rebecca E. Glover, C.Finn McQuaid , Ioana D. Olaru, Karin Gallandat, Quentin J. Leclerc, Naomi M. Fuller, Sam J. Willcocks, Rumina Hasan, Esther van Kleef, Clare Chandler. eLife 2021;10:e64139 DOI: https://doi.org/10.7554/eLife.64139
Year 2020 02. Validation of Bedaquiline Phenotypic Drug Susceptibility Testing Methods and Breakpoints: A Multilibrary, Multicounty Study. Kaniga K, Aono A, Borroni E, Cirillo DM, Desmaretz C, Hasan R, Joseph L, Mitarai S, Shakoor S, Torrea G, Ismail NA, Omar SV. J Clin Microbiol. 2020 Jan 22. pii: JCM.01677-19. (Impact Factor: 4.59). https://pubmed.ncbi.nlm.nih.gov/31969421/ 03. Is enhancing the professionalism of healthcare providers critical to tackling antimicrobial resistance in low- and middle-income countries? Mishal Khan; Sothavireak Bory; Sonia Rego; Sovanthida Suy; Anna Durrance-Bagale; Zia Sultana; Sophea Chhorn; Socheata Phou; Chanra Prien; Sotheara Heng; Johanna Hanefeld; Rumina Hasan; Vonthanak Saphonn. Hum Resour Health. 2020 Feb 11;18(1):10. https://pubmed.ncbi.nlm.nih.gov/32046723/ 04. Nontuberculous Mycobacterial Infections - a neglected and emerging problem. Ahmed I, Tiberi S, Farooqi J, Jabeen K, Yeboah-Manu D, Migliori GB, Hasan R. Int J Infect Dis. 2020 Mar; 92S:S46-S50. https://pubmed.ncbi.nlm.nih.gov/32114200/ 05. Post TB treatment infectious complications. Hsu D, Irfan M, Jabeen K, Iqbal N, Hasan R, Migliori GB, Zumla A, Visca D, Centis R, Tiberi S. Int J Infect Dis. 2020 Mar; 92S:S41-S45. https://pubmed.ncbi.nlm.nih.gov/32114203/ 06. Commemorating World TB Day 2020: "IT'S TIME" - It's Time to End the Global TB Epidemic. (Editorial). Tiberi S, Migliori GB, Muhwa Chakaya J, Kaesava T, Al Abri SS, Wejse C, Goletti D, Kapata N, Sotgiu G, Bomanji J, Zellweger JP, Hasan R, Irfan M, Ahmed I, Pshenichnaya N, Vasilieva I, Yeboah- Manu D, Alffenaar JW, Kim HY, Centis R, Cirillo DM, Alagna R, D'Ambrosio L, Cui X, Cao B, Maeurer M, Harries AD, Ippolito G, Raviglione M, Zumla A, Petersen E. Commemorating World TB Day 2020: "IT'S TIME" - It's Time to End the Global TB Epidemic. (Editorial). Int J Infect Dis. 2020 Mar;92S: S1- S4. https://pubmed.ncbi.nlm.nih.gov/32145464/ 07. What are the barriers to implementing national antimicrobial resistance actions plans? A novel mixed-methods policy analysis in Pakistan. Mishal Khan, Ana Durrance-Bagale, Zia Sultana, Rumina Hasan, Johanna Hanefeld. Health Policy and Planning. August 2020 https://doi.org/10.1093/heapol/czaa065 08. Setting a baseline for global urban virome surveillance in sewage. Nieuwenhuijse DF, Oude Munnink BB, Phan MVT, et al. (including Rumina Hasan as part of Global Sewage Surveillance project consortium). Sci Rep. 2020;10(1):13748. Published 2020 Aug 13. https://pubmed.ncbi.nlm.nih.gov/32792677/ 09. Eggerthella lenta bacteraemia in endometrial adenocarcinoma - a case report from Pakistan. Tazeen Fatima, Rumina Hasan, Samia Tariq. J Pak Med Assoc 2020 Jun;70(6):1079-1080. https://pubmed.ncbi.nlm.nih.gov/32810111/ 10. A Multimethod, Multicountry Evaluation of Breakpoints for Bedaquiline Resistance Determination. Nazir Ismail, Akio Aono, Emanuele Borroni, Daniela Cirillo, Christel Desmaretz, Rumina Hasan, Satoshi Mitara, Sadia Shakoor, Gabriela Torrea, Koné Kaniga, and Shaheed Omar. Antimicrob Agents Chemother 2020 Aug 20;64(9):e0047 20. doi: 10.1128/AAC.00479-20. Print 2020 Aug 20. https://pubmed.ncbi.nlm.nih.gov/32660992/ 11. Covid -19, misinformation, and antimicrobial resistance. Mehreen Arshad, Syed Faisal Mahmood, Mishal Khan, Rumina Hasan (Editorial). BMJ 2020; 371:m4501. https://www.bmj.com/content/371/bmj.m4501.full 12. Breakpoint broth microdilution plate’ for susceptibility testing of Gram-negative bacilli against colistin sulfate. Imran Ahmed, Sidra Laiq, Najma Shsheen, Khalid Wahab, Joveria Farooqi, Asima Shahid, Rumina Hasan, Sadia Shakoor. Practical Laboratory Medicine. 2020 Nov. Vol 22 e00192. https://www.sciencedirect.com/science/article/pii/S2352551720301554?via%3Dihub
Year 2019 13. Efflux pump as alternate mechanism for drug resistance in Mycobacterium tuberculosis. (Review). Akbar Kanji, Rumina Hasan, Zahra Hasan. Indian J Tuberc. 2019 Jan;66(1):20-25. (Impact Factor: 0.38). https://pubmed.ncbi.nlm.nih.gov/30797276/ 14. Ceftriaxone-resistant Salmonella Typhi Outbreak in Hyderabad City of Sindh, Pakistan: High Time for the Introduction of Typhoid Conjugate Vaccine. Yousafzai MT, Qamar FN, Shakoor S, Saleem K, Lohana H, Karim S, Hotwani A, Qureshi S, Masood N, Rauf M, Khanzada JA, Kazi M, Hasan R. Clin Infect Dis. 2019 Feb 15;68 (Supplement_1):S16-S21. (Impact Factor: 9.1) https://pubmed.ncbi.nlm.nih.gov/30767003/ 15. Utility of the microcolony method for evaluation of multidrug-resistant tuberculosis patients in Karachi, Pakistan. Irfan Seema; Rao Nisar Ahmed; Irfan Muhammad; Iftikhar Irim; Azizullah Zahida; Jabeen Kauser; Hasan Rumina. The International Journal of Tuberculosis and Lung Disease 2019, 23 (7), 838-843. (Impact factor: 2.0) https://pubmed.ncbi.nlm.nih.gov/31439116/ 16. Global monitoring of antimicrobial resistance based on metagenomics analyses of urban sewage. Hendriksen RS, Munk P, Njage P, van Bunnik B, McNally L, Lukjancenko O, Röder T, Nieuwenhuijse D, Pedersen SK, Kjeldgaard J, Kaas RS, Clausen PTLC, Vogt JK, Leekitcharoenphon P, van de Schans MGM, Zuidema T, de Roda Husman AM, Rasmussen S, Petersen B; Global Sewage Surveillance project consortium, Amid C, Cochrane G, Sicheritz-Ponten T, Schmitt H, Alvarez JRM, Aidara-Kane A, Pamp SJ, Lund O, Hald T, Woolhouse M, Koopmans MP, Vigre H, Petersen TN, Aarestrup FM. Nat Commun. 2019 Mar 8;10(1):1124. (Impact Factor: 11.88). https://pubmed.ncbi.nlm.nih.gov/30850636/ 17. Common Alternative Diagnoses among a Pediatric Hospital‑Based Cohort Evaluated for Tuberculosis in Karachi, Pakistan: The Need for Facilitated Referral in Tuberculosis Clinics. Sadia Shakoor, Fatima Mir, Rumina Hasan. Int J. of Mycobacteriology 2019; 8(1); January-March. (Impact Factor: 0.82).https://pubmed.ncbi.nlm.nih.gov/30860178/ 18. LMICs as reservoirs of AMR': a comparative analysis of policy discourse on antimicrobial resistance with reference to Pakistan. Khan MS, Durrance-Bagale A, Legido-Quigley H, Mateus A, Hasan R, Spencer J, Hanefeld J. Health Policy Plan. 2019 Apr 11. pii: czz022. (Impact Factor: 2.71). https://pubmed.ncbi.nlm.nih.gov/30977804/ 19. Antimicrobial susceptibility against metronidazole and carbapenem in clinical anaerobic isolates from Pakistan. Yusra Shafquat; Kauser Jabeen; Joveria Farooqi; Kiran Mehmood; Seema Irfan; Rumina Hasan; Afia Zafar. Antimicrobial Resistance & Infection Control 2019 Jun 14; 8:99. (Impact Factor: 3.22). https://pubmed.ncbi.nlm.nih.gov/31210928/ 20. Antibiotic-Resistant Enteric Infection. Shakoor S, Platts-Mills JA, Hasan R. In Infectious Diseases Clinics of North America on Emerging and Re-Emerging Infections 2019 Dec;33(4): 1105-1123. (Impact Factor: 4.757) https://pubmed.ncbi.nlm.nih.gov/31668193/ 21. Accuracy of genotype MTBDRplus line probe assay in patients with tuberculous pleural effusion: comparison with clinical and culture-based diagnosis. Irfan M, Idrees F, Jabeen K, Zubairi ABS, Butt S, Hasan R. Infect Dis (Lond). 2019 Dec 4:1-7 (Impact Factor: 2.191). https://pubmed.ncbi.nlm.nih.gov/31797723/
Year 2018 22. Methylation in Mycobacterium tuberculosis is lineage specific with associated mutations present globally. Jody Phelan , Paola Florez de Sessions , Leopold Tientcheu , Joao Perdigao, Diana Machado, Rumina Hasan, Zahra Hasan, Indra Bergval, Richard Anthony, Ruth McNerney, Martin Antonio , Isabel Portugal , Miguel Viveiros, Susana Campino , Martin Hibberd. Scientific Reports. 2018 8:160 (Impact Factor: 4.525) https://pubmed.ncbi.nlm.nih.gov/29317751/. 23. Genome-wide analysis of multi- and extensively drug-resistant Mycobacterium tuberculosis. Francesc Coll, Jody Phelan, Hill-Cawthorne, Mridul B Nair, Kim Mallard, Shahjahan Ali, Abdallah M Abdallah, Saad Alghamdi, Mona Alsomali, Abdallah O Ahmed, Stephanie Portelli, Yaa Oppong, Adriana Alves, Theolis Barbosa Bessa, Susana Campino, Maxine Caws, Anirvan Chatterjee, Amelia C Crampin, Keertan Dheda, Nicholas Furnham, Judith R Glynn, Louis Grandjean, Dang Thi Minh Ha, Rumina Hasan, Zahra Hasan, Martin L Hibberd, Moses Joloba, Edward C. Jones-López, Tomoshige Matsumoto, Anabela Miranda, David J Moore, Nora Mocillo, Stefan Panaiotov, Julian Parkhill, Carlos Penha, João Perdigão, Isabel Portugal, Zineb Rchiad, Jaime Robledo, Patricia Sheen, Nashwa Talaat Shesha, Frik A Sirgel, Christophe Sola, Erivelton de Oliveira Sousa, Elizabeth M Streicher, Paul Van Helden, Miguel Viveiros, Robert M Warren, Ruth McNerney, Arnab Pain, Taane G Clark. Nature Genetics, 22 January 2018 doi:10.1038/s41588-017-0029-0. (Impact Factor: 27.12 ) https://www.nature.com/articles/s41588-017-0029-0. 24. Emergence of an extensively drug-resistant (XDR) Salmonella Typhi harbouring a promiscuous plasmid encoding resistance to fluoroquinolones and third-generation cephalosporins. Elizabeth Klemm, Sadia Shakoor, Andrew Page, Farah Qamar, Kim Judge, Dania Saeed, Vanessa Wong, Timothy Dallman, Satheesh Nair, Stephen Baker, Ghazala Shaheen, Shahida Qureshi, Mohammad Yousafzai, Mohammad Saleem, Zahra Hasan, Gordon Dougan, and Rumina Hasan. MBio January/February 2018 Volume 9 Issue 1 e00105-18. Impact Factor: 6.74). https://pubmed.ncbi.nlm.nih.gov/29463654/ 25. Strengthening tuberculosis and antimicrobial resistance control programmes through integration. Rumina Hasan, Sadia Shakoor, Johanna Hanefeld, Mishal Khan. Bull World Health Organ. 2018 Mar 1;96(3):194-200. (Impact Factor: 6.81). https://pubmed.ncbi.nlm.nih.gov/29531418/ 26. Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance study. Zignol M, Cabibbe AM, Dean AS, Glaziou P, Alikhanova N, Ama C, Andres S, Barbova A, Borbe-Reyes A, Chin DP, Cirillo DM, Colvin C, Dadu A, Dreyer A, Driesen M, Gilpin C, Hasan R, Hasan Z, Hoffner S, Hussain A, Ismail N, Kamal SMM, Khanzada FM, Kimerling M, Kohl TA, Mansjö M, Miotto P, Mukadi YD, Mvusi L, Niemann S, Omar SV, Rigouts L, Schito M, Sela I, Seyfaddinova M, Skenders G, Skrahina A, Tahseen S, Wells WA, Zhurilo A, Weyer K, Floyd K, Raviglione MC. Lancet Infect Dis. 2018 Mar 21. pii: S1473- 3099(18)30073-2. (Impact Factor: 28.4), https://pubmed.ncbi.nlm.nih.gov/29574065/ 27. Mycobacterium tuberculosis detection in pulmonary specimens from prospective immigrants; Laboratory data from Pakistan. Yusra Shafqat, Kausar Jabeen, Muhammad Irfan, Khalid Wahad, Rumina Hasan. Infectious Disease Journal of Pakistan. 2018 Jul-Sept 27(3): 70-73. (Impact Factor: NA). 28. Complete Genome Sequence of Buffalopox virus Isolated from Human Pock Lesions in Karachi, Pakistan in 2005. Babak Afrough, Afia Zafar, Rumina Hasan, Roger Hewson. Genome Announc. 2018 May 24;6(21). pii: e00444-18. doi: 10.1128/genomeA.00444-18. (impact factor: 0.78). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968727/ 29. High heterotrophic counts in potable water and antimicrobial resistance among indicator organisms in two peri-urban communities of Karachi, Pakistan. Sadia Shakoor; Imran Ahmed; Saima Mukhtiar; Israr Ahmed; Farzeen Hirani; Shazia Sultana; Rumina Hasan. BMC Res Notes. 2018 Jun 4;11(1):350. (Impact Factor: 1.09). https://pubmed.ncbi.nlm.nih.gov/29866160/ 30. Trends, Associations, and Antimicrobial Resistance of Salmonella Typhi and Paratyphi in Pakistan. Jai Das, Rumina Hasan, Afia Zafar, Imran Ahmed, Aamer Ikram, Summiya Nizamuddin, Saleel Fatima, Nauman Akbar, Faisal Sultan and Zulfiqar Bhutta. Am J Trop Med Hyg. 2018 Jul 25. (Impact Factor: 2.56). https://pubmed.ncbi.nlm.nih.gov/30047366/ 31. Late diagnosis of Human Immunodeficiency Virus infections in high risk groups in Karachi, Pakistan. Zahra Hasan, Sharaf Shah, Rumina Hasan, Shoaib Rao, Manzoor Ahmed, Mars Stone, Michael Busch. International Journal of STD & AIDS. 2018 Aug 13:956462418785264.(Impact Factor: 1.494)https://pubmed.ncbi.nlm.nih.gov/30103664/ 32. Integrating standardized whole genome sequence analysis with a global Mycobacterium tuberculosis antibiotic resistance knowledgebase. Ezewudo M, Amanda Borens, Alvaro Chiner Oms , Miotto Paolo, Leonid Chindelevitch, Starks, Angela M., Richard Liwski, ZIGNOL, Matteo, GILPIN, Christopher, tkohl, Stefan Niemann. Warren, RM, Derrick Crook , Sebastien Gagneux, Sven Hoffner, Rodrigues Camilla, Iñaki Comas, David Alland; Leen Rigouts; clange
Year 2017 34. Pattern of first- and second-line drug resistance among retreatment cases of pulmonary tuberculosis in Pakistan. Javaid, Arshad; Hasan, Rumina; Zafar, Afia; Chaudry, Muhammad Akram; Qayum, Shaheena; Qadeer, Ejaz; Shaheen, Zubair; Agha, Naeem; Rizvi, Nadeem; Chima, Muhammad Kamran; Khan, Abdur Rab; Ghafoor, Abdul; Khan, Saulat Ullah; Akhtar, Sohail; Chaudhary, Muhammad Khalid; Iqbal, Zafar Hussain; Ansarie, Mosavir; Ahmad, Nafees. International Journal of Tuberculosis and Lung Disease (2017) 21(3):303–308. (Impact Factor: 2.0). https://pubmed.ncbi.nlm.nih.gov/28225340/ 35. Strategies for management of latent tuberculosis in endemic settings: building evidence" (Editorial). Sadia Shakoor, Rumina Hasan. International Journal of Tuberculosis and Lung Disease (2017) Aug 1;21(8):836. (Impact Factor: 1.62). https://pubmed.ncbi.nlm.nih.gov/28786789/ 36. Rapid detection of in vitro antituberculous drug resistance among smear-positive respiratory samples using microcolony detection-based direct drug susceptibility testing method. Irim Iftikhar, Seema Irfan, Joveria Farooqi, Zahida Azizullah, Rumina Hasan. International Journal of Mycobacteriology 2017; 6(2) 117-121. (Impact Factor: 0.52). https://pubmed.ncbi.nlm.nih.gov/28559510/ 37. Diagnostic performance of genoType® MTBDRplus line probe assay in bronchoalveolar lavage for pulmonary tuberculosis diagnosis in sputum scarce and smear-negative patients. Farah Idrees, Muhammad Irfan, Kauser Jabeen, Joveria Farooqi, Rumina Hasan. International Journal of Mycobacteriology 2017; 6(2) 122-126. (Impact Factor: 0.52). https://pubmed.ncbi.nlm.nih.gov/28559511/ 38. Phenotypic low-level isoniazid resistance as a marker to predict ethionamide resistance in Mycobacterium tuberculosis. Salima Qamar, Joveria Q Farooqi, Kausar Jabeen, Rumina Hasan. International Journal of Mycobacteriology 2017; 6(2) 167-170. (Impact Factor: 0.52). https://pubmed.ncbi.nlm.nih.gov/28559519/ 39. Frequency of colistin and fosfomycin resistance in carbapenem-resistant Enterobacteriaceae from a tertiary care hospital in Karachi. Qamar S, Shaheen N, Shakoor S, Farooqi J, Jabeen K, Hasan R. Infection and Drug Resistance 2017: 10 231-236. (Impact Factor: 3:00). https://pubmed.ncbi.nlm.nih.gov/28814888/. 40. Evaluation of Xpert MTB/RIF testing for rapid diagnosis of childhood pulmonary tuberculosis in children by Xpert MTB/RIF testing of stool samples in a low resource setting. Zahra Hasan; Sadia Shakoor; Fehmina Arif; Aisha Mehnaz; Alnoor Akber; Marium Haider; Akbar Kanji; Rumina Hasan. BMC Research Notes 2017 Sep 8; 10(1):473. (Impact Factor: 1.15). https://pubmed.ncbi.nlm.nih.gov/28886729/ 41. Single Nucleotide Polymorphisms in Efflux pumps genes in Extensively Drug Resistant Mycobacterium tuberculosis isolates from Pakistan. Akbar Kanji, Rumina Hasan, Asho Ali, Ambreen Zaver, Ying Zhang, Kehkashan Imtiaz, Wanliang Shi, Taane Clark, Ruth McNerney, Shoaib Rao, Samreen Shafiq. Tuberculosis 2017 Dec; 107:20-30. (Impact Factor: 2.79). https://pubmed.ncbi.nlm.nih.gov/29050768/ 42. Readiness for antimicrobial resistance (AMR) surveillance in Pakistan; a model for laboratory strengthening. Dania Khalid Saeed; Rumina Hasan; Mahwish Naim; Afia Zafar; Erum Khan; Kausar Jabeen; Seema Irfan; Imran Ahmed; Mohammad Zeeshan; Zabin Wajidali; Joveria Farooqi; Sadia Shakoor; Abdul Chagla; Jason Rao. Antimicrob Resist Infect Control. 2017 Sep 29; 6:101. (Impact Factor: 3.68). https://pubmed.ncbi.nlm.nih.gov/29021895/. 43. A standardised method for interpreting the association between mutations and phenotypic drug- resistance in Mycobacterium tuberculosis. Paolo Miotto, Belay Tessema, Elisa Tagliani, Leonid Chindelevitch, Angela M. Starks, Claudia Emerson, Debra Hanna, Peter S. Kim, Richard Liwski, Matteo Zignol, Christopher Gilpin, Stefan Niemann, Claudia M. Denkinger, Joy Fleming, Robin M. Warren, Derrick Crook, James Posey, Sebastien Gagneux, Sven Hoffner, Camilla Rodrigues, Iñaki Comas, David M. Engelthaler, Megan Murray, David Alland, Leen Rigouts, Christoph Lange, Keertan Dheda, Rumina Hasan, Uma Devi K. Ranganathan, Ruth McNerney, Matthew Ezewudo, Daniela M. Cirillo, Marco Schito, Claudio U. Köser, Timothy C. Rodwell. Eur Respir J. 2017 Dec 28;50(6). pii: 1701354. doi: 10.1183/13993003.01354-2017. Print 2017 Dec. (Impact Factor: 12.2). https://pubmed.ncbi.nlm.nih.gov/29284687/
Year 2016 44. Exploring the evidence base for national and regional policy interventions to combat resistance. Osman A Dar, Rumina Hasan, Jørgen Schlundt, Stephan Harbarth, Grazia Caleo, Fazal K Dar, Jasper Littmann, Mark Rweyemamu, Emmeline J Buckley, Mohammed Shahid, Richard Kock, Henry Lishi Li, Haydar Giha, Mishal Khan, Anthony D So, Khalid M Bindayna, Anthony Kessel, Hanne Bak Pedersen, Govin Permanand, Alimuddin Zumla, John-Arne Røttingen, David L Heymann. The Lancet; Antimicrobials: access and sustainable effectiveness. Lancet. 2016 Jan 16;387(10015):285- 95. (Impact Factor: 28.4)https://pubmed.ncbi.nlm.nih.gov/26603921/ 45. Flaviviruses as a Cause of Undifferentiated Fever in Sindh Province, Pakistan: A Preliminary Report. Erum Khan, Joveria Farooqi, Kelli L. Barr, Dhani Prakoso, Amna Nasir, Akbar Kanji, Sadia Shakoor, Fasil Malik, Rumina Hasan, John A. Lednicky, Maureen T. Long. Frontiers in Public Health. 2016 Feb 16; 4:8. (Impact Factor: 2.03) https://pubmed.ncbi.nlm.nih.gov/26909342/ 46. Recombination in pe/ppe genes contributes to genetic variation in Mycobacterium tuberculosis lineages. Jody E. Phelan, Francesc Coll, Indra Bergval, Richard M. Anthony, Rob Warren, Samantha L. Sampson, Nicolaas C. Gey van Pittius, Judith R. Glynn, Amelia C. Crampin, Adriana Alves, Theolis Barbosa Bessa, Susana Campino, Keertan Dheda, Louis Grandjean1, Rumina Hasan, Zahra Hasan, Anabela Miranda, David Moore, Stefan Panaiotov, Joao Perdigao, Isabel Portugal, Patricia Sheen, Erivelton de Oliveira Sousa, Elizabeth M. Streicher, Paul D. van Helden, Miguel Viveiros, Martin L. Hibberd, Arnab Pain, Ruth McNerney and Taane G. Clark. BMC Genomics. 2016 Feb 29;17: 151. doi: 10.1186/s12864-016-2467-y. (Impact Factor: 2.03) http://bmcgenomics.biomedcentral.com/articles/10.1186/s12864-016-2467-y 47. Antibiotic susceptibility in Streptococcus pneumoniae, Haemophilus influenzae and Streptococcus pyogenes in Pakistan: a review of results from the Survey of Antibiotic Resistance (SOAR) 2002–15. A. Zafar, R. Hasan, S. Nizamuddin, N. Mahmood, S. Mukhtar, F. Ali, I. Morrissey, K. Barker and D. Torumkuney. J Antimicrob Chemother 2016; 71 Suppl 1: i103–i109. doi:10.1093/jac/dkw076. (Impact factor: 3.73). https://pubmed.ncbi.nlm.nih.gov/27048578/ 48. Barriers to Implementation of Optimal Laboratory Biosafety Practices in Pakistan. Shakoor S, Shafaq H, Hasan R, Qureshi SM, Dojki M, Hughes MA, Zaidi AK, Khan E. Health Secur. 2016 Jul- Aug;14(4):214-9. (Impact Factor: 5.06) https://pubmed.ncbi.nlm.nih.gov/27400192/ 49. Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project. Zignol M, Dean AS, Alikhanova N, Andres S, Cabibbe AM, Cirillo DM, Dadu A, Dreyer A, Driesen M, Gilpin C, Hasan R, Hasan Z, Hoffner S, Husain A, Hussain A, Ismail N, Kamal M, Mansjö M, Mvusi L, Niemann S, Omar SV, Qadeer E, Rigouts L, Ruesch-Gerdes S, Schito M, Seyfaddinova M, Skrahina A, Tahseen S, Wells WA, Mukadi YD, Kimerling M, Floyd K, Weyer K, Raviglione MC. Lancet Infect Dis. 2016 Jul 7. pii: S1473- 3099(16)30190-6. (Impact Factor: 28.4) https://pubmed.ncbi.nlm.nih.gov/27397590/ 50. Dissemination and spread of New Delhi Metallo-beta-lactamase-1 Superbugs in hospital settings. Khan E, Irfan S, Sultan BA, Nasir A, Hasan R. J Pak Med Assoc. 2016 Aug;66(8):999-1004. (Impact Factor: 0.41) https://pubmed.ncbi.nlm.nih.gov/27524536/ 51. Mycobacterial contamination of bronchoscopes: Challenges and possible solutions in low resource settings. DK Saeed, S Shakoor, S Irfan, R Hasan. International Journal of Mycobacteriology 5 (2016) 408-411. (Impact Factor: 0.52) https://pubmed.ncbi.nlm.nih.gov/27931681/ 52. Extrapulmonary tuberculosis among females in South Asia – gap analysis. Jaishri Mehraj, Zain Yar Khan, Dania Saeed, Sadia Shakoor, Rumina Hasan. International Journal of Mycobacteriology 5 (2016) 392-399. (Impact Factor: 0.52). https://www.sciencedirect.com/science/article/pii/S2212553116301923?via%3Dihub 53. Fluoroquinolone consumption and-resistance trends in Mycobacterium tuberculosis and other respiratory pathogens: Ecological antibiotic pressure and consequences in Pakistan, 2009–2015. S Shakoor, S Tahseen, K Jabeen, R Fatima, FR Malik, AH Rizvi, R Hasan. Int J Mycobacteriol. 2016 Dec; 5(4):392-399. (Impact Factor: 0.52). https://pubmed.ncbi.nlm.nih.gov/27931679/ 54. Fast Dissemination of New HIV-1 CRF02/A1 Recombinants in Pakistan. Chen Y, Hora B, DeMarco T, Shah SA, Ahmed M, Sanchez AM, Su C, Carter M, Stone M, Hasan R, Hasan Z, Busch MP, Denny TN, Gao F. PLoS One. 2016 Dec 14; 11(12): e0167839. (Impact Factor: 2.77). https://pubmed.ncbi.nlm.nih.gov/27973597/
Year 2015 55. Rapid determination of anti-tuberculosis drug resistance from whole-genome sequences. Coll F, McNerney R, Preston MD, Guerra-Assunção JA, Warry A, Hill-Cawthorne G, Mallard K, Nair M, Miranda A, Alves A, Perdigão J, Viveiros M, Portugal I, Hasan Z, Hasan R, Glynn JR, Martin N, Pain A, Clark TG. Genome Med. 2015 May 27;7(1):51. (Impact Factor: 5.84) https://pubmed.ncbi.nlm.nih.gov/26019726/ 56. Etiology of bacteremia in young infants in six countries. Hamer DH, Darmstadt GL, Carlin JB, Zaidi AK, Yeboah-Antwi K, Saha SK, Ray P, Narang A, Mazzi E, Kumar P, Kapil A, Jeena PM, Deorari A, Chowdury AK, Bartos A, Bhutta ZA, Adu-Sarkodie Y, Adhikari M, Addo-Yobo E, Weber MW; Hasan R as part of Young Infants Clinical Signs Study Group. Pediatr Infect Dis J. 2015 Jan; 34(1):e1-8. (Impact Factor: 2.72). https://pubmed.ncbi.nlm.nih.gov/25389919/
Year 2014 57. Drug resistant tuberculosis: Challenges of urbanization (Editorial), Rumina Hasan. International Journal of Mycobacteriology 3 (2014) 79-81. (Impact Factor: 0.52) https://pubmed.ncbi.nlm.nih.gov/26786327/ 58. Mycobacterium tuberculosis Central Asian Strain (CAS) lineage strains in Pakistan reveal lower diversity of MIRU loci than other strains. Asho Ali; Zahra Hasan; Sana Jafri; Raunaq Inayat; Rumina Hasan. International Journal of Mycobacteriology 3 (2014) 108-116. (Impact Factor: 0.52) https://pubmed.ncbi.nlm.nih.gov/26786332/ 59. Are TB control programmes in South Asia ignoring children with disease? A situational analysis. Sadia Shakoor, Farah Naz Qamar, Fatima Mir, Anita Zaidi, Rumina Hasan. Arch Dis Child 2015 Feb; 100(2): 198-205 (Impact Factor: 3.258) https://pubmed.ncbi.nlm.nih.gov/25480926/ 60. Whole genome sequencing based characterization of extensively drug-resistant Mycobacterium tuberculosis isolates from Pakistan. Asho Ali, Zahra Hasan, Ruth McNerney, Kim Mallard, Grant Hill- Cawthorne, Francesc Coll, Mridul Nair, Arnab Pain, Taane G. Clark, Rumina Hasan; PLoS One. 2015 Feb 26;10 (2): e0117771. (Impact Factor: 2.77) https://pubmed.ncbi.nlm.nih.gov/25719196/ 61. Characterization of genomic variations in SNPs of PE_PGRS genes reveals deletions and insertions in extensively drug resistant (XDR) M. tuberculosis strains from Pakistan. Akbar Kanji, Zahra Hasan, Asho Ali, Ruth McNerney, Kim Mallard, Francesc Coll, Grant Hill-Cawthorne, Mridul Nair, Taane G. Clark, 11 Ambreen Zaver, Sana Jafri, Rumina Hasan. Int J Mycobacteriol (2015) Mar 4(1): 73-79. (Impact Factor: 0.52) https://pubmed.ncbi.nlm.nih.gov/26655202/. 62. Fluoroquinolone resistant tuberculosis; implications in settings with weak healthcare systems (Invited review). Kausar Jabeen, Sadia Shakoor, Rumina Hasan. Int J Mycobacteriol. 2015 Mar; 4 Suppl 1:47-8. doi: 10.1016/j.ijmyco.2014.10.046. (Impact Factor: 0.52) https://pubmed.ncbi.nlm.nih.gov/25809767/
Year 2013 63. Community Acquired Pneumonia (Review). Muhammad Irfan, Joveria Farooqi, Rumina Hasan. Curr Opin Pulm Med. 2013 Feb 15. (Invited review). (Impact Factor: 3.00) https://pubmed.ncbi.nlm.nih.gov/23422417/ 64. Susceptibility testing of extensively drug resistant and pre-extensively drug resistant Mycobacterium tuberculosis against levofloxacin, linezolid, and amoxicillin-clavulanate. Imran Ahmed, Kauser Jabeen, Raunaq Inayat, Rumina Hasan. Antimicrob. Agents Chemother. June 2013; 57:6 2522-2525. (Impact Factor: 4.71) https://pubmed.ncbi.nlm.nih.gov/23507286/ 65. Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts. Marais BJ, Lönnroth K, Lawn SD, Migliori GB, Mwaba P, Glaziou P, Bates M, Colagiuri R, Zijenah L, Swaminathan S, Memish ZA, Pletschette M, Hoelscher M, Abubakar I, Hasan R, Zafar A, Pantaleo G, Craig G, Kim P, Maeurer M, Schito M, Zumla A. Lancet Infect Dis. 2013 May;13 (5):436-48. doi: 10.1016/S1473-3099(13)70015-X. Epub 2013 Mar 24. (Impact Factor: 28.4) https://pubmed.ncbi.nlm.nih.gov/23531392/ 66. Unusual sex differences in tuberculosis notifications across Pakistan and the role of environmental factors. Mishal S. Khan, Muhammad Shoaib Khan, Rumina Hasan, Peter Godfrey-Faussett. Eastern Mediterranean Health Journal 2013; 19(9): 821-825. (Impact Factor: 0.66) https://pubmed.ncbi.nlm.nih.gov/24313046/ 67. Identification of non-tuberculous mycobacteria isolated from clinical specimens at a tertiary care hospital: a cross-sectional study. Imran Ahmed, Kauser Jabeen and Rumina Hasan. BMC Infectious Diseases 2013, 13:493(Impact Factor: 2.82) https://pubmed.ncbi.nlm.nih.gov/24148198/ 68. Non-tuberculous mycobacteria in extra-pulmonary specimens: role of nosocomial transmission in Pakistan. Imran Ahmed, Kauser Jabeen, and Rumina Hasan. Infectious Disease Journal. 2013; 22(03):581-583.(Impact Factor: NA) https://www.pakmedinet.com/journal/13/1/September/2013/22(3)
Year 2012 69. Dengue Infection in Asia; A Regional Concern. Erum Khan and Rumina Hasan. J. Postgraduate Medical Institute, 2012; 26(1): 01-06. (Impact Factor: 0.05) http://www.jpmi.org.pk/index.php/jpmi/article/download/1195/1103 70. Characterising M. tuberculosis isolates from Karachi, Pakistan: Drug resistance and genotypes. Afsheen Ayaz, Zahra Hasan, Sana Jafri, Raunaq Inayat, Rafique Mangi, Abid Ali Channa, Faisal Riaz Malik, Asho Ali, Yasraba Rafiq, Rumina Hasan. International Journal of Infectious Diseases 2012; 16(2012) e303-e309. (Impact Factor: 2.88) https://pubmed.ncbi.nlm.nih.gov/22365136 71. Detection of Helicobacter pylori using Molecular Genetic Assay. Sana Rajper, Erum Khan, Zubair Ahmad, Syed Muhammad Zaheer Alam, Adil Akbar, Rumina Hasan. Infectious Diseases Journal of Pakistan 2012; 21 (1): 391-394. (Impact Factor: NA) 72. Line probe assay for detection of rifampicin and isoniazid resistant tuberculosis in Pakistan. Joveria Qais Farooqi, Erum Khan, Syed Muhammad Zaheer Alam, Asho Ali, Zahra Hasan, Rumina Hasan. J.Pakistan Medical Association 2012; 62(8): 767-772. (Impact Factor: 0.41)https://pubmed.ncbi.nlm.nih.gov/23862246/ 73. Overcoming drug resistant tuberculosis (invited review). Rumina Hasan, Zahra Hasan, Sabira Tahseen. European Infectious Disease 2012; Volume 6 Issue 2 (Impact Factor: NA) https://www.researchgate.net/publication/286474321 74. Childhood Tuberculosis in Household Contacts of Newly Diagnosed TB Patients. Srichand Batra, Afsheen Ayaz, Ali Murtaza, Shakil Ahmad, Rumina Hasan, Ruth Pfau. PLoS ONE 2012; 7(7): e40880. (Impact Factor: 2.77) https://pubmed.ncbi.nlm.nih.gov/22859957/ 75. Risk factors for multidrug-resistant tuberculosis in urban Pakistan: A multicenter case–control study. Ahmad AM, Akhtar S, Hasan R, Khan JA, Hussain SF, Rizvi N. International Journal of Mycobacteriology 2012; 1(3): 137-142. (Impact Factor: 0.52) https://pubmed.ncbi.nlm.nih.gov/26787209/ 76. Multidrug resistant Mycobacterium tuberculosis amongst Category I & II failures and Category II relapse patients. Abdul Ghafoor, Jaishri Mehraj, Nek Dad Afridi, Yasraba Rafiq, Hans-Uwe Wendl- Richter, Rumina Hasan. International Journal of Mycobacteriology 2012; 1(3): 118-123. (Impact Factor: 0.52)https://pubmed.ncbi.nlm.nih.gov/26787206/ 77. Tropical bacterial gastrointestinal infections (Review). Sadia Shakoor, Rumina Hasan, and Anita K. M. Zaidi. Infectious Diseases Clinics of North America. 2012 Jun;26(2):437-53 https://pubmed.ncbi.nlm.nih.gov/22632648/ 78. Effectiveness of Vi capsular polysaccharide typhoid vaccine among children: A cluster randomized trial in Karachi, Pakistan. M. Imran Khan, Sajid Bashir Soofi, R. Leon Ochiai, Mohammad Atif Habib, Shah Muhammad Sahito, S. Qamaruddin Nizami, Camilo J. Acosta, John D. Clemens, Zulfiqar A. Bhutta DOMI Typhoid Karachi Vi Effectiveness Study Group1. Vaccine Volume 30, Issue 36, 3 August 2012, Pages 5389–5395. (Impact Factor: 3.23) https://pubmed.ncbi.nlm.nih.gov/22721899/ 79. Invasive candidiasis in Pakistan: Clinical characteristics, species distribution and antifungal susceptibility. Farooqi JQ, Jabeen K, Saeed N, Iqbal N, Malik B, Lockhart SR, Zafar A, Brandt ME, Hasan R. J Med Microbiol. 2012 Oct 25. (Impact Factor: 2.11) https://pubmed.ncbi.nlm.nih.gov/23105021/ 80. High Isoniazid Resistance Rates in Rifampicin Susceptible Mycobacterium Tuberculosis Pulmonary Isolates from Pakistan. Naima Fasih, Yasraba Rafiq, Kausar Jabeen, Rumina Hasan. PLoS One. 2012;7 (11): e50551. doi: 10.1371/journal.pone.0050551. (Impact Factor: 2.77) https://pubmed.ncbi.nlm.nih.gov/23226311/
YEAR 2011 81. Occurrence of RD149 and RD152 deletions in M. tuberculosis strains from Pakistan. Akbar Kanji, Zahra Hasan, Mahnaz Tanveer, Rabia.Laiq and Rumina Hasan. J Infect Dev Ctries 2011; 5(2):106- 113. (Impact Factor: 1.33) https://pubmed.ncbi.nlm.nih.gov/21389589/ 82. Rhinocladiella mackenziei as an emerging cause of cerebral phaeohyphomycosis in Pakistan: a case series. Kausar Jabeen, Joveria Farooqi, Afia Zafar, Bushra Jamil, Syed Faisal Mahmood, Farheen Ali, Noureen Saeed, Abrar Barakzai, Arsalan Ahmed, Erum Khan, Mary E. Brandt, Rumina Hasan. Clinical Infectious Diseases 2011; 52(2): 213-217. (Impact Factor: 9.1) https://pubmed.ncbi.nlm.nih.gov/21288846/ 83. Fluoroquinolone-resistant Mycobacterium tuberculosis, Pakistan, (2005-2009). Kauser Jabeen, Sadia Shakoor, Shazia Chishti, Afsheen Ayaz, Rumina Hasan. Emerg Infect Dis. 2011; 17 (3): 564- 565. (Impact Factor: 7.42) https://pubmed.ncbi.nlm.nih.gov/21392465/ 84. Impact and challenges of infection control in a public sector intensive care unit: Experience from a low resourced country. Muhammad S Khan, Saeeda Haider, Safia Z Siddiqui, Afia Zafar, Faisal Malik, Rumina Hasan. International Journal of Infection Control. 2011; 7(3) (Impact Factor: 0.15). http://www.ijic.info/article/view/6333/6139 85. Molecular and epidemiologic characterization of clinical isolates of carbapenem resistant Acinetobacter baumannii from public and private sector intensive care units in Karachi, Pakistan. Seema Irfan, Jane F Turton, Jaishri Mehraj, Safia Zafar Siddiqui, Saeeda Haider, Afia Zafar, Bushra Memon, Osama Afzal, Rumina Hasan. J Hosp Infect. 2011 Jun;78 (2):143-8. (Impact Factor: 3.35) https://pubmed.ncbi.nlm.nih.gov/21459477/ 86. Primary Drug Resistance to Antituberculous Drugs in Punjab Pakistan. Arshad Javaid, Shamshad Awan, Zafar Syed, Zafar Iqbal, Chaudhary Akram, Karam Shah, Zubair Shaheen, Saulat Khan, Rumina Hasan, Afia Zafar. Pakistan J. Chest Medicine 2011; Jan-Mar 17(1): 03-09. 09 (Impact Factor: NA)https://www.pjcm.net/index.php/pjcm/article/view/133 87. Presence of RD149 deletions in the M. tuberculosis Central Asian Strain1 isolates affects growth and TNFα induction in THP-1 monocytes. Akbar Kanji, Zahra Hasan, Mehnaz Tanveer, Raunaq Mahboob, Sana Jafri, and Rumina Hasan. PloS ONE August 2011. Volume 6(8) e24178. (Impact Factor: 2.77) https://pubmed.ncbi.nlm.nih.gov/21904612/ 88. Genetic regulation of the ram A locus and its expression in clinical isolates of Klebsiella pneumonia. Rosenblum R, Khan E, Gonzalez G, Hasan R, Schneiders T. Int J Antimicrob Agents. 2011 Jul;38 (1):39-45. Epub 2011 Apr 22. (Impact Factor: 0.08) https://pubmed.ncbi.nlm.nih.gov/21514798/ 89. Characterization of mutations conferring extensive drug resistance (XDR) to M. tuberculosis isolates in Pakistan. Asho Ali, Rumina Hasan, Kauser Jabeen, Nusrat Jabeen, Ejaz Qadeer, and Zahra Hasan. Antimicrobial Agents and Chemotherapy, Dec. 2011; Vol. 55(12): 5654–5659. (Impact Factor: 2.108) https://pubmed.ncbi.nlm.nih.gov/21911575/ 90. Mycobacterium tuberculosis Genotypes in patients developing pulmonary tuberculosis related acute respiratory distress syndrome. Nawal Salahuddin, Mahnaz Tanveer, Nisar Rao, Saeed Akram, Zahra Hasan, Rumina Hasan. Sri Lanka Journal of Critical Care 2011; Vol 2 (1): 20-24. (Impact Factor: NA) https://sljcc.sljol.info/articles/abstract/10.4038/sljcc.v2i1.2370/
YEAR 2010 91. Increase in isolation of extended spectrum beta-lactamase producing multidrug resistant non typhoidal Salmonella in Pakistan. K. Jabeen, A. Zafar, S. Irfan, E. Khan, V. Mehraj, R. Hasan. BMC Infectious Diseases 2010, 10:10. (Impact Factor: 2.82) https://pubmed.ncbi.nlm.nih.gov/20409348/ 92. Prevalence of Multi-drug resistance TB and its associated Risk factors in Karachi Pakistan. Muslima Ejaz, Amna Rehana Siddiqui, Yasraba Rafiq, Faisal Malik, Abid Channa, Rafique Mangi, Faiza Habib, Rumina Hasan. Trans R Soc Trop Med Hyg. 2010 Aug; 104(8):511-7 (Impact Factor: 2.3)https://pubmed.ncbi.nlm.nih.gov/20427065/ 93. In-vitro activity of tigecycline and other tetracyclines against carbapenem-resistant acinetobacter spp: report from a tertiary care centre in Karachi, Pakistan. Sadia Shakoor, Erum Khan, Afia Zafar, Rumina Hasan. Chemotherapy 2010; 56(3):184-9. (Impact Factor: 2.108) https://pubmed.ncbi.nlm.nih.gov/20551633/ 94. Increased isolation of ESBL producing Klebsiella pneumoniae with emergence of Carbapenam resistant isolates in Pakistan: Report from a tertiary care hospital laboratory. E.Khan, M.Ejaz, A. Zafar, K. Jabeen, S.Shakoor, Raunaq, R. Hasan. JPMA; 2010 60 (3): 186-189. (Impact Factor: 0.41) https://pubmed.ncbi.nlm.nih.gov/20225774/ 95. Emergence of CTX-M Group-1 ESBL Producing Klebsiella pneumoniae, from tertiary care center Karachi, Pakistan. Erum Khan, Thamarai Schneiders, Afia Zafar, Erum Aziz, Asra Parekh, Rumina Hasan. J Infect Dev Ctries (2010); 4(8): 468-471. (Impact Factor: 1.33) https://pubmed.ncbi.nlm.nih.gov/20818098/ 96. Extensively Drug Resistant Tuberculosis, Pakistan. Rumina Hasan, Kausar Jabeen, Asho Ali, Yasraba Rafiq, Rabia Laiq, Babar Malik, Mahnaz Tanveer, Ramona Groenheit, Solomon Ghebremichael, Sven Hoffner and Zahra Hasan. Emerg Infect Dis. (2010) Sep; 16(9):1473-5. (Impact Factor: 7.42) https://pubmed.ncbi.nlm.nih.gov/20735937/ 97. Prevalent Genotypes of Methicillin Resistant Staphylococcus aureus; Report from Pakistan. Zafar A, Stone M, Ibrahim S, Parveen Z, Hasan Z, Khan E, Hasan R, Wain J, Bamford K. J.Med Microbiol. 2010 Sep 30. (Impact Factor: 2.11) https://pubmed.ncbi.nlm.nih.gov/20884770/ 98. Demographic and Clinical Features of Dengue Fever in Pakistan from 2003-2007: A Retrospective Cross-sectional Study. Erum Khan, Mehreen Kisat, Nabil Khan, Amna Nasir, Salma Ayub, Rumina Hasan. PLOS One 2010 Sep 13;5(9): e12505. (Impact Factor: 2.77)https://pubmed.ncbi.nlm.nih.gov/20856935/ 99. Burden of Haemophilus influenzae type b disease in Pakistani children. Zaidi AK, Khan H, Sherali AR, Lasi R; Sindh Meningitis Study Group. East Mediterr Health J. 2010 Jun; 16(6):590-4. (Impact Factor: 0.66) https://pubmed.ncbi.nlm.nih.gov/20799584/ 100. Use of p-nitrobenzoic acid in 7H10 agar for identification of mycobacterium tuberculosis complex: a field study" (short communication). Sadia Shakoor, Tanwir Ahsan, Kauser Jabeen, Mehmood Raza, Rumina Hasan. IJTLD 2010 14(12):1644–1646. (Impact Factor: 1.62) https://pubmed.ncbi.nlm.nih.gov/21144253/ 101. Fluoroquinolone resistance amongst Mycobacterium tuberculosis strains from Karachi, Pakistan; Data from community based field clinics. Rafiq Y, Jabeen K, Hasan R, Jafri S, Laiq R, Malik F, Mangi R, Channa A, Hasan Z. Antimicrob Agents Chemother. 2010 Dec 6. (Impact Factor: 4.7) https://pubmed.ncbi.nlm.nih.gov/21135180/ 102. Cohort analysis of directly observed treatment outcomes for tuberculosis patients in urban Pakistan. Saeed Akhtar, Shafquat Rozi, Franklin White, Rumina Hasan. IJTLD (2011). Jan 15(1); 90- 96. (Impact Factor: 1.62) https://pubmed.ncbi.nlm.nih.gov/21276303/ 103. Inducible clindamycin resistance due to expression of erm genes in Staphylococcus aureus: Report from a Tertiary Care Hospital Karachi, Pakistan. Naima Fasih, Seema Irfan, Afia Zafar, Erum Khan, Rumina Hasan. JPMA 2010; 60(9): 750-753. (Impact Factor: 0.41) https://pubmed.ncbi.nlm.nih.gov/21381584/ 104. Clonal dissemination of VanA positive Enterococcus species in Tertiary Care Hospitals in Karachi, Pakistan. Naima Fasih, Afia Zafar, Erum Khan, Kausar Jabeen, Rumina Hasan. JPMA 2010; 60(10): 805-809. (Impact Factor: 0.41) https://pubmed.ncbi.nlm.nih.gov/21381606/.
YEAR 2009 105. Variation in Salmonella enterica serovar Typhi IncHI1 plasmids during the global spread of resistant typhoid fever. Minh-Duy Phan, Claire Kidgell, Satheesh Nair, Kathryn Holt, Jason Hinds, Philip Butcher, Fiona Cooke, Nicholas J. Thomson, Richard Titball, Zulfiquar Bhutta, Rumina Hasan, Gordon Dougan and John Wain. Antimicrob Agents Chemother. 2009 Feb; 53(2):716-27. (Impact Factor: 4.7)https://pubmed.ncbi.nlm.nih.gov/19015365/ 106. M. tuberculosis Central Asian Strain 1 MDR isolates have more mutations in rpoB and katG genes compared with other genotypes. Ali A, Hasan Z, Moatter T, Tanveer M, Hasan R. Scand J Infect Dis. 2009; 41(1):37-44. https://pubmed.ncbi.nlm.nih.gov/19012077/ 107. Correction: (Impact Factor: 1.47) https://pubmed.ncbi.nlm.nih.gov/21073264/ 108. Controlled Evaluation of BACTECTM PEDS PLUSTM/F and BACTECTM LYTIC/10 Anaerobic/F Media for the Isolation of Salmonella Typhi and Paratyphi A from Blood. Reller ME, Zaidi AK, Sultana S, Azeem S, Hanif B, Qureshi S, Hasan R, Bhutta Z, Akhter R, Goldmann DA. Clin Microbiol. 2009 Jan; 47(1):245-6. (Impact Factor: 4.16)https://pubmed.ncbi.nlm.nih.gov/19005140/ 109. Frequency of isolation of various subtypes and antimicrobial resistance of Shigella from urban slums of Karachi, Pakistan. Zafar A, Hasan R, Nizami SQ, von Seidlein L, Soofi S, Ahsan T, Chandio S, Habib A, Bhutto N, Siddiqui FJ, Rizvi A, Clemens JD, Bhutta ZA. Int J Infect Dis. 2009 Jan 7. (Impact Factor: 1.80) https://pubmed.ncbi.nlm.nih.gov/19135399/ 110. Pseudogene accumulation in the evolutionary histories of Salmonella enterica serovars Paratyphi A and Typhi. Holt KE, Thomson NR, Wain J, Langridge GC, Hasan R, Bhutta ZA, Quail MA, Norbertczak H, Walker D, Simmonds M, White B, Bason N, Mungall K, Dougan G, Parkhill J. BMC Genomics. 2009 Jan 21; 10(1):36. https://pubmed.ncbi.nlm.nih.gov/19159446/ 111. Trends of Mycobacterium Tuberculosis resistance in Pakistan (1990-2007). Rumina Hasan, Kauser Jabeen, Vikram Mehraj, Farhan Zafar, Ashfaq Ali Khan, Qaiser Hassan, Iqbal Azam, Muhammad Masood Kadir. Int J Infect Dis. 2009 Apr 13. (Impact Factor: 1.80) https://pubmed.ncbi.nlm.nih.gov/19369103/ 112. Infection control education: Impact on ventilator-associated pneumonia rates in an Intensive Care Unit of Pakistan. M.S. Khan, S.Z. Siddiqui, S. Haider, A. Zafar, F. Zafar, R.N. Khan, K. Afshan, A. Jabeen, M.S. Khan, R. Hasan. Trans R Soc Trop Med Hyg. 2009 Mar 31. (Impact Factor: 2.3) https://pubmed.ncbi.nlm.nih.gov/19342068/ 113. Reduced TNF-α and IFN-ɣ responses to Central Asian strain 1 and Beijing isolates of M.tuberculosis as compared with H37Rv. Mahnaz Tanveer, Zahra Hasan, Akbar Kanji, Rabia Hussain and Rumina Hasan. Trans R Soc Trop Med Hyg. 2009 Jun; 103(6):581-7. (Impact Factor: 2.3) https://pubmed.ncbi.nlm.nih.gov/19375139/ 114. Surveillance of pneumococcal meningitis among children in Sindh, southern Pakistan. Zaidi AK, Khan H, Lasi R, Mahesar W; Sindh Meningitis Group. Clin Infect Dis. 2009 Mar 1; 48 Suppl 2: S129- 35. (Impact Factor: 9.1) https://pubmed.ncbi.nlm.nih.gov/19191608/ 115. Evaluation of two ELISA assay kits against RT-PCR for diagnosis of dengue virus infection in a hospital setting in Karachi, Pakistan. Khan E, Mehraj V, Nasir A, Khan NA, Billoo B, Moatter T, Hasan R. J Pak Med Assoc. 2009 Jun; 59(6):390-4. / (Impact Factor: 0.41) https://pubmed.ncbi.nlm.nih.gov/19534376 116. Prevalence of ST26 among untreated smear-positive tuberculosis patients from Karachi indicating ongoing transmission. Sadia Shakoor, Mahnaz Tanveer, Yasraba Rafiq, Zahra Hasan, Arshad Javaid, Nadeem Rizvi, Nadeem Rehman, Rumina Hasan. Scand J Infect Dis. 2009 Aug 13:1-6. (Impact Factor: 1.47) https://pubmed.ncbi.nlm.nih.gov/19681020/
YEAR 2008 117. Metallo-β-Lactamas-Producing Clinical Isolates of Acinetobacter spp. And Pseudomonas aeruginosa from Intensive Care Patients of a Tertiary Care Hospital. S.Irfan, A.Zafar, D.Guhar, T.Ahsan, R.Hasan. Indian Journal of Medical Microbiology 2008; 26(3): 243-245. (Impact Factor: 0.98) https://pubmed.ncbi.nlm.nih.gov/18695323/ 118. Clinical signs that predict sever illness in children under the age of 2 months: a multi-centre study. As part of young infant study group. Lancet 2008; 371: 135-142. (Impact Factor: 28.4) https://pubmed.ncbi.nlm.nih.gov/18191685/ 119. Prevalence of primary multidrug resistance to anti-tuberculosis drugs in Pakistan. Javaid A, Hasan R, Zafar A, Ghafoor A, Pathan AJ, Rab A, Sadiq A, Akram CM, Burki I, Shah K, Ansari M, Rizvi N, Khan SU, Awan SR, Syed ZA, Iqbal ZH, Shaheen Z, Ur Rehman N. Int J Tuberc Lung Dis. 2008 Mar; 12(3):326-31. (Impact Factor: 2.30) https://pubmed.ncbi.nlm.nih.gov/18284840/ 120. Increased frequency of isolation of Vibrio cholerae O1 serotype Inaba replacing prevailing serotype Ogawa in Karachi, Pakistan. Jabeen K, Zafar A, Hasan R. Eastern Mediterranean Health Journal 2008; 14(3): 564-570. (Impact Factor: 0.66) https://pubmed.ncbi.nlm.nih.gov/18720620/ 121. Emergence of carbapenem resistant gram-negative rods and vancomycin resistant Gram-positive organisms in bacteremic isolates of febrile neutropenic patients; A descriptive study. Seema Irfan, Faiza Idrees, Vikram Mehraj, Faiza Habib, Salman Adil and Rumina Hasan. BMC Infect Dis. 2008 Jun 9; 8:80. (Impact Factor: 2.53)https://pubmed.ncbi.nlm.nih.gov/18541017/ 122. Co-circulations of two genotypes of dengue virus in 2006 out-break of Dengue Hemorrhagic Fever in Karachi Pakistan. Erum Khan, Rumina Hasan, Vikram Mehraj, Amna Nasir, Joveria Siddiqui, Roger Hewson. Journal of Clinical Virology 2008; 43(2); 176-179. (Impact Factor: 3.1) https://pubmed.ncbi.nlm.nih.gov/18639489/ 123. Antibiotic resistance among Salmonella enterica Serovars Typhi and Paratyphi A in Pakistan (2001- 2006). Rumina Hasan, Afia Zafar, Zohair Abbas, Vikram Mahraj, Faisal Malik, Anita Zaidi. Journal of Infection in Developing Countries 2008; 2(4): 289-294. (Impact Factor: 1.19) https://pubmed.ncbi.nlm.nih.gov/19741291/ 124. TB in Pakistan (Guest Editorial) Rumina Hasan. Infectious Diseases Journal of Pakistan 2008; Jan- Mar; 17(1):2. (Impact Factor:1.191) 125. An assessment of Mantoux test in the Diagnosis of Tuberculosis in a BCG-Vaccinated, Tuberculosis Endemic Area. Bushra Jamil, Salima Qamaruddin, Arif Sarwari, Rumina Hasan. Infectious Diseases Journal of Pakistan 2008; Jan-Mar; 17(1):18-22. (Impact Factor: NA) https://pakmedinet.com/13403 126. Rapid detection of Mycobacterium tuberculosis in Sputum Samples by Microscopic Observation Methods. Seema Irfan, Rumina Hasan, Akber.Kanji, Qaiser Hassan, Iqbal Azam. Infectious Diseases Journal of Pakistan 2008; Jan-Mar; 17(1):10-13. (Impact Factor: NA) https://www.pakmedinet.com/13401 127. Molecular Epidemiology of Mycobacterium tuberculosis. Asho Ali, Zahra Hasan, Rumina Hasan. Infectious Diseases Journal of Pakistan 2008; Apr-Jun; 17(2):61-65. (Impact Factor: NA) https://pakmedinet.com/13396. 128. Primary Drug Resistance to Antituberculous Drugs in NWFP Pakistan. Arshad Javaid, Abdul Ghafoor, Abdul Rab, Anila Basit, Zia Ullah, Shaukat Ali, Afia Zafar, Rumina Hasan. J. Pakistan Medical Association 2008; 58(8): 437-440. (Impact Factor: 0.41) https://pubmed.ncbi.nlm.nih.gov/18822641/ 129. Primary Drug Resistance to Anti-tuberculous Drugs in Karachi. Javaid A, Rizvi N, Ansari M, Sadiq A, Burki IS, Rehman NU, Hasan R, Zafar A. J Coll Physicians Surg Pak. 2008 Nov; 18(11):699-702. (Impact Factor: 0.48). https://pubmed.ncbi.nlm.nih.gov/18983794/ 130. Genotyping and Drug resistance patterns of M.tuberculosis strains in Pakistan. Mahnaz Tanveer, Zahra Hasan, Amna R Siddiqui, Asho Ali, Akbar Kanji, Solomon Ghebremicheal and Rumina Hasan. BMC Infect Dis. 2008 Dec 24; 8(1):171. (Impact Factor: 2.53) https://pubmed.ncbi.nlm.nih.gov/19108722/ 131. A study of typhoid fever in five Asian countries: disease burden and implications for controls. Ochiai RL, Acosta CJ, Danovaro-Holliday MC, Baiqing D, Bhattacharya SK, Agtini MD, Bhutta ZA, Canh do G, Ali M, Shin S, Wain J, Page AL, Albert MJ, Farrar J, Abu-Elyazeed R, Pang T, Galindo CM, von Seidlein L, Clemens JD; Domi Typhoid Study Group. Bull World Health Organ. 2008 Apr; 86(4):260- 8. (Impact Factor: 6.8) https://pubmed.ncbi.nlm.nih.gov/18438514/
YEAR 2007 132. MODS assay for the diagnosis of TB. (Letter to the Editor) Hasan R, Irfan S. N Engl J Med. 2007 Jan 11;356 (2):188. (Impact Factor: 53.48) https://pubmed.ncbi.nlm.nih.gov/17225284/ 133. Dengue virus serotype 3, Karachi, Pakistan. Bushra Jamil, Rumina Hasan, Afia Zafar, Kevin Bewley, John Chamberlain, Valerie Mioulet, Moira Rowlands, Roger Hewson. Emerging Infectious Diseases 2007; 13(1): 182-182. (Impact Factor: 6.45) https://pubmed.ncbi.nlm.nih.gov/17370547/ 134. Nosocomial buffalopoxvirus infection, Karachi, Pakistan. Afia Zafar, Robert Swanepoel, Roger Hewson, Mazhar Nizam, Altaf Ahmed, Akhtar Husain, Antoinette Grobbelaar, Kevin Bewley, Valerie Mioulet, A. Barry Dowsett., Linda Easterbrook, Rumina Hasan. Emerging Infectious Diseases, 2007; Jun; 13(6):902-4. (Impact Factor: 6.45) https://pubmed.ncbi.nlm.nih.gov/17553232/ 135. Multidrug-resistant Salmonella enterica serovar Paratyphi A harbour IncHI1 plasmids similar to those found in serovar Typhi. Holt KE, Thomson NR, Wain J, Phan MD, Nair S, Hasan R, Bhutta ZA, Quail MA, Norbertczak H, Walker D, Dougan G, Parkhill J. J.Bacteriol. 2007; Jun; 189(11):4257-64. Epub 2007 Mar 23. (Impact Factor: 3.22) https://pubmed.ncbi.nlm.nih.gov/17384186/ 136. Hyperendemic pulmonary tuberculosis in peri-urban areas of Karachi, Pakistan. Saeed Akhtar, Franklin White, Rumina Hasan, Shafquat Rozi, Mohammad Younus, Faiza Ahmed, Sara Husain and Bilquis S Khan. Biomedical Central (BMC) Public Health 2007; May 3; 7: 70. / (Impact Factor: 0.86) https://pubmed.ncbi.nlm.nih.gov/17477870 137. Dengue out-break Karachi 2006: Experience at a tertiary care center. E.Khan, Siddiqui J, Sadia Shakoor, Vikram Mehraj, Bushra Jamil, Rumina Hasan. Trans R Soc Trop Med Hyg. 2007 Nov; 101(11):1114-9. Epub 2007 Aug 13. (Impact Factor: 2.3)https://pubmed.ncbi.nlm.nih.gov/17706259/. 138. Characterization of Mycobacterium tuberculosis Central Asian Strain1 (CAS1) using Mycobacterial Interspersed Repetitive Unit (MIRU-VNTR). Asho Ali, Zahra Hasan, Mahnaz Tanveer, Rehana A Siddiqui, Solomon Ghebremichael, Gunilla Kallenius and Rumina Hasan. BMC Microbiol. 2007 Aug 9; 7: 76. (Impact Factor: 3.31) https://pubmed.ncbi.nlm.nih.gov/17686185/
YEAR 2006 139. Incidence of acute respiratory infections in children 2 month to 5 years of age in periurban communities in Karachi, Pakistan. Shaikh Qamaruddin Nizami, Zulfiqar Ahmed Bhutta, Rumina Hasan. J. Pakistan Medical Association 2006; 56(4): 163-167. (Impact Factor: 0.41) https://pubmed.ncbi.nlm.nih.gov/16711336/ 140. Assessment of primary resistance in multi-drug resistance (MDR) tuberculosis patient. Seema Irfan, Qaiser Hassan, Rumina Hasan. J Pak Med Assoc. 2006 Sep; 56(9):397-400. (Impact Factor: 0.41) https://pubmed.ncbi.nlm.nih.gov/17091751/ 141. Emergence of quinolone resistant Neisseria gonorrhoea in Pakistan. Kausar Jabeen, Erum Khan, Rumina Hasan. J. Sexually Trans Diseases and Aids 2006; 17(1): 30-33. (Impact Factor: 1.49) https://pubmed.ncbi.nlm.nih.gov/16409676/ 142. Typhoid fever in children: some epidemiological considerations from Karachi, Pakistan. F.J. Siddiqui, F. Rabbani, R.Hasan, S.Q.Nizami, Z.A. Bhutta. Int. J. Infect. Dis. May 2006; 10(3): 215-22. (Impact Factor: 3.04)https://pubmed.ncbi.nlm.nih.gov/16431148/ 143. Spoligotyping of Mycobacteruim tuberculosis isolates in Pakistan reveals MDR associated Beijing strains and the predominance of a Central Asian type strain. Zahra Hasan, Mahnaz Tanveer, Akbar Kanji, QaisaR Hasan, Solomon Ghebremichael, Rumina Hasan. J. Clinical Microbiology May 2006; 44(5): 1763-1768. (Impact Factor: 4.03) https://pubmed.ncbi.nlm.nih.gov/16672404/ 144. Enhanced disease surveillance through private health care sector cooperation in Karachi, Pakistan: experience from a vaccine trial. Khan MI, Sahito SM, Khan MJ, Wassan SM, Shaikh AW, Maheshwari AK, Acosta CJ, Galindo CM, Ochiai RL, Rasool S, Peerwani S, Puri MK, Ali M, Zafar A, Hassan R, von Seidlein L, Clemens JD, Nizami SQ, Bhutta ZA. Bull World Health Organ. 2006 Jan; 84(1):72-7. Epub 2006 Feb 23. (Impact Factor: 6.81) https://pubmed.ncbi.nlm.nih.gov/16501718/ 145. Evaluation of microcolony detection method and phage assay for rapid detection of Mycobacterium tuberculosis complex in sputum sample. Seema Irfan, Rumina Hasan, Akber.Kanji, Qaiser Hassan, Iqbal Azam. Southeast Asian J Trop Med and Public Health 2006; 37(6): 1187-95. (Impact Factor: 0.60) https://pubmed.ncbi.nlm.nih.gov/17333776/
YEAR 2005 146. Vi antigen expression in Salmonella enterica serovar Typhi clinical isolates from Pakistan. John Wain, Deborah House, Afia Zafar, Stephen Baker, Sateesh Naire, Claire Kidgell, Zulfiqar Bhutta, Gordon Dougan and Rumina Hassan. J. Clin. Microbiology 2005; 43(3): 1158-65. (Impact Factor: 2.03)https://pubmed.ncbi.nlm.nih.gov/15750077/ 147. Role of chest X’ray in diagnosis of lower respiratory tract infections in children less than 5 years of age in community. S.Q.Nizami, Z. Bhutta, R. Hasan, Y.A. Husen. Pakistan J. Medical Science 2005; 21(4); 417-421. (Impact Factor: 0.137) https://www.pjms.com.pk/issues/octdec05/article/article6.html 148. Frequency and sensitivity pattern of Extended Spectrum beta Lactamase producing isolates in a tertiary care hospital laboratory of Pakistan. Kauser Jabeen, Afia Zafar, Rumina Hasan. J. Pakistan Medical Association 2005; 55(10): 436-439. (Impact Factor: 0.41) https://pubmed.ncbi.nlm.nih.gov/16304852/ 149. Naladixic acid screening test in detection of decreased fluoroquinolone susceptibility in Salmonella typhi isolated from blood. Zafar A, Ibrahim NG, Ahsan T, Abbas Z, Zaidi A, Hasan R. J. Coll Physicians Surg Pak. 2005; 15(7); 413-417. (Impact Factor: 0.48) https://pubmed.ncbi.nlm.nih.gov/16197870/ 150. Crimean-Congo Haemorrhagic fever: Experience at a tertiary care hospital in Karachi, Pakistan. Bushra Jamil, Rumina Hasan, Arif Sarwari, Jane Burton, Roger Hewson, Chris Clegg. Transactions Royal Society of Tropical Medicine and Hygiene 2005; 99, 577-584. (Impact Factor: 2.3) https://pubmed.ncbi.nlm.nih.gov/15935414/ 151. Typhoid and paratyphoid fever. (Comment). R. Hasan, Cooke FJ, Nair S, Harish BN, Wain J. Lancet 2005; 366(9497): 1603-1604. (Impact Factor: 28.4) https://pubmed.ncbi.nlm.nih.gov/16271635/
YEAR 2004 152. Penicillin Resistant Streptococcus pneumoniae at a tertiary care centre in Pakistan. Yawar M. Yacoob, QaisaR Hasan, Rumina Hasan. Tropical Doctor 2004; 34(2): 121-2. (Impact Factor: 0.407). https://pubmed.ncbi.nlm.nih.gov/15117154/ 153. Evaluation of frequency of isolation and trends in antibiotic resistance among Campylobacter isolates over 11-year period. Nazish Gul Ibrahim, Afia Zafar, Rumina Hasan. J Pakistan Medical Association. J. Pakistan Medical Association 2004; 54(6): 291-294. (Impact Factor: 0.41) https://pubmed.ncbi.nlm.nih.gov/15366792/ 154. Impact of antibiotic usage on resistance in micro-organisms; Urinary tract infection with E. coli as a case in point. Nasim Sabir, Erum Khan, Latif Sheikh, Rumina Hasan. J Pakistan Medical Association 2004; 54(9): 472-5. (Impact Factor: 0.41) https://pubmed.ncbi.nlm.nih.gov/15518371/ 155. Crimean - Congo haemorrhagic fever virus: Sequence analysis of the Small RNA segment from a collection of viruses worldwide. R. Hewson, J. Chamberlain, G. Lloyd, B. Jamil, R. Hasan, A. Gmyl, L Gmyl, S. E. Smirnova, A. Lukashev, G. Karganova and C. Clegg. Virus Research 2004; 15.102(2): 185- 9. (Impact Factor: 2.48) https://pubmed.ncbi.nlm.nih.gov/15084400/ 156. PCR identification and automated ribotyping of Pseudomonas aeruginosa clinical isolates from intensive care patients. Arif Sarwari, Rumina Hasan, Chuan Bian Lim, Yvonne Ng, Charis Ng, and Sara Zaman. Scandanavian J. Infectious Diseases 2004 36(5): 324-9. (Impact Factor: 2.5)https://pubmed.ncbi.nlm.nih.gov/15287378/ 157. Evidence of segment reassortment in Congo Crimean Haemorrhagic Fever Virus. Roger Hewson, Anatoliy Gmyl, Larissa Gmyl, Svetlana E. Smirnova, Galina Karganova, Bushra Jamil, Rumina Hasan, John Chamberlain and Christopher Clegg. J. General Virology 2004; 85: 3059-3070. (Impact Factor: 2.8) https://pubmed.ncbi.nlm.nih.gov/15448369/
YEAR 2003 158. Sever Acute Respiratory Syndrome- A Review (invited review). Erum Khan, Rumina Hasan, Afia Zafar. Infectious Diseases Journal of Pakistan 2003; 12(2): 47-48. (Impact Factor: 2.5) 159. Caesarian section wound infection: Pathogen or contaminants? (A case report). Bushra Jamil, Syed Tanvir Ahsan, Hasnain Zafar, Rumina Hasan. Infectious Diseases Journal of Pakistan 2003; 12(2): 57-58. (Impact Factor: 2.5) 160. Resurgence of Vibrio cholere 0139 in Pakistan. Kauser Jabeen, Rumina Hasan. J. Pakistan Medical Association 2003; 53(8): 335-338. (Impact Factor: 0.41) https://pubmed.ncbi.nlm.nih.gov/14558737/ 161. Comparison of combined disc and double disc method for the detection of ESBL. Kauser Jabeen, Afia Zafar, Rumina Hasan. J Pakistan Medical Association 2003; 53(11): 534-536. (Impact Factor: 0.41) https://pubmed.ncbi.nlm.nih.gov/14738259/ 162. Typhoid Fever (Letter to the editor). Anita K.M. Zaidi, Rumina Hasan, Zulfiqar A.Bhutta. New England Journal of Medicine 2003; 348(12): 1182-84. (Impact Factor: 53.48) https://pubmed.ncbi.nlm.nih.gov/12647735/ 163. Use of contaminated drug and its implication: Developing world scenario. (Letter to the editor). Afia Zafar, Rumina Hasan, Nasim Sabir. Lancet 2003; 362: 169-170. (Impact Factor: 28.4) https://pubmed.ncbi.nlm.nih.gov/12867122/
YEAR 2002 164. Nosocomial and ventilator associated pneumonias. Hasan R, Babar SI. Developing country perspective. Current Opinions in Pulmonary Medicine 2002; Volume 8 (3) (Invited review) (Impact Factor: 2.5). https://pubmed.ncbi.nlm.nih.gov/11981307/ 165. Diagnosis of Typhoid Fever by Dot Enzyme Immunoassay in an Endemic Region. Erum Khan, Iqbal Azam, Shahid Ahmed, Rumina Hasan. J. Pakistan Medical Association 2002; 52(9): 415-417. (Impact Factor: 0.41) https://pubmed.ncbi.nlm.nih.gov/12532577/ 166. Emergence of Vancomycin-Resistant Enterococcus faecium at a Tertiary Care Hospital in Karachi, Pakistan. Erum Khan, Arif Sarwari, Rumina Hasan, Salma Ghori, Ijlal Babar, Frances O’Brien, Warren Grubb. J. Hospital Infection 2002; 52(4); 292-296. (Impact Factor: 3.35) https://pubmed.ncbi.nlm.nih.gov/12473475/
YEAR 2001 167. A low-cost Intervention for Cleaner Drinking Water in Karachi, Pakistan. Luby, S., Agboatwallah, M., Raza A, Sobel, J., A., Mintz, E., Baier K., Rahbar M, Quereshi S, Hasan R, Ghouri F, Hoekstra, M, Gangarosa, E. International Journal of Infectious Diseases 2001; 5 (3); 144-150. (Impact Factor: 2.88). https://pubmed.ncbi.nlm.nih.gov/11724671/. 168. Microbiological effectiveness of hand washing with soap in an urban squatter settlement, Karachi, Pakistan. Luby, S., Agboatwallah, M., Raza A, Sobel, J., A., Mintz, E., Baier K., Hoekstra, M, Rahbar M, Hasan R, Quereshi S, Gangarosa, E. Epidemiol Infect. 2001; 127; 237-244. (Impact Factor: 0.853) https://www.researchgate.net/publication/11659822. 169. Quinolone resistance in neutropenic patients: the effect of prescribing policy in the UK and Pakistan. Zaidi Y, Hastings M, Murray J, Hasan R, Khurshid M, Mahendra P. Clin Lab. Haem. 2001; 23; 39-42. (Impact Factor: NA)
YEAR 1997 170. Immune response profile in patients with active tuberculosis in a BCG vaccinated area. Hussain, R., Toossi, Z., Hasan, R., Jamil, B., Dawood, G, Ellner, J.J. S.E. Asian J. Trop. Med. Pub. Hlth. 1997; 28: 764-773. (Impact Factor: 0.6) https://pubmed.ncbi.nlm.nih.gov/9656400/ 171. Diagnosis of Chlamydia trachomatis infections Hasan, Rumina. Infectious Diseases Journal of Pakistan 1997. (Impact Factor: NA)
YEAR 1999 172. Acute gastreoenteritis caused by E. coli O157:H7 in Pakistani Children. (Research Letter). Mufti, P., Bhutta, Z.A, Hasan, R. J. Tropical Pediatrics 1999; 45(4): 253-4. (Impact Factor: 1.28). https://academic.oup.com/tropej/article/45/4/253/1695003
YEAR 1996 173. Pulmonary tuberculosis in a BCG vaccinated: relationship of disease severity with immunological and haematological parameters and drug resistance patterns. Hussain, R., Hasan, R., Khurshid, M., Sturm, A.W., Ellner, J.J. and Dawood, G. S.E. Asian J. Trop. Med. Pub. Hlth 1996; 27(2) 257-262. (Impact Factor: 0.6). https://pubmed.ncbi.nlm.nih.gov/9279986/. 174. Invasive retroperitoneal infection due to Basidiobolus vanarum in an 8-year-old boy. A case report and review of literature. Nazir, Z., Hasan, R., Pervaiz, S., Alam, M. and Moazam, F. Annals of Tropical Paediatrics 1996; 17: 161-164. (Impact Factor: NA) https://pubmed.ncbi.nlm.nih.gov/9230980/
YEAR 1993 175. Antigen coated latex particles as a model system for probing monocyte responses in leprosy. Hasan, R, Jamil, S., Dockrell, Hazel, Chiang, T.J., and Hussain, R. Infection and Immunity 1993; 61: 3724- 3729. (Impact Factor: 3.2). https://pubmed.ncbi.nlm.nih.gov/8395470/ .
YEAR 1992 176. Specificity of lymphocytotoxic Auto antibodies (LCABs) found in the serum of leprosy patients: Class I MHC Antigens. Rasheed, F.N., Locniskar, M., McCloskey, D.J., Hasan, R., Chiang, T.J., Rose, P., Soldenhoff, R.de., Festenstein, H., and McAdam K.P.W.J. Lep. Rev. 1992; 62, 13-20. (Impact Factor: 0.75). https://pubmed.ncbi.nlm.nih.gov/2034020/. 177. Detection of high titers of T. gondii antibodies in sera of patients with leprosy in Pakistan. Hussain, R., Jamil, S., Kifayet, A., Dockrell, H., Zaman, V., and Hasan, R. Trans. Roy. Soc. Trop. Med. Hyg. 1992; 86:259-262. (Impact Factor: 2.82) https://pubmed.ncbi.nlm.nih.gov/1412648/.
YEAR 1990 178. Quantitations of IgM antibodies to the M. leprae synthetic disaccharide can predict early bacterial multiplication in leprosy. Hussain, R., Jamil, S., Kifayet, A., Firdausi, F., Dockrell, H., Lucas, S., Hasan, R. Int. J. Lep. 1990; 58(3): 491-502. https://pubmed.ncbi.nlm.nih.gov/2205684/. 179. The diagnosis of tuberculosis. (Review). Hasan, R, R. Hussain, and A.W. Sturm. Pakistan J. Surg. 1990; 6: 86-88. (Impact Factor: NA).
YEAR 1989 180. T cell recognition of the 18kD antigen Mycobacterium leprae. Dockrell, H.M., Stoker, N.G., Lee, S.P., Jackson, M., Grant, K.A., Jouy, N.F., Lucas, S.B., Hasan, R., Hussain, R., McAdam, K.P.W.J., Infect. Immun. 1989; 57(7): 1979-1983. https://pubmed.ncbi.nlm.nih.gov/2659530/. (Impact Factor: 3.2). https://pubmed.ncbi.nlm.nih.gov/2659530/. 181. Serum lymphocytoxic activity in leprosy. Rasheed, F.N., Locniskar, M., McCloskey, D.J., Hasan, R., Chiang, T, J., Rose, P., Soldenhoff, R.de., Festenstein, H., and McAdam, K.P.W.J. Clin. Exp. Immunol. 1989; 76:39. (Impact Factor: 3.4). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1541899/ . 182. Quantitative Antibody Elisa for Leprosy. Hasan, R., Dockrell H., Chiang, T., Hussain, R. Int. J. Lep. 1989; 57 (4): 766-776. (Impact Factor: NA) https://pubmed.ncbi.nlm.nih.gov/2681459/.
BOOK CHAPTERS: 1. Sadia Shakoor, Zahra Hasan, R Hasan. Epidemiological, ecological and public health effects of antibiotics and AMR/ARGs. In Antibiotics and Antimicrobial Resistance Genes: Environmental Occurrence and Treatment Technologies. Pages 255-269. Ist Edition, Springer International Publishing. 2019 2. Hasan, R., Nordin, A.C., Shakoor, S., Keenum, I. and Vinneras, B. 2019. Salmonella, Enteric Fevers, and Salmonellosis. In: J.B. Rose and B. Jiménez-Cisneros, (eds) Global Water Pathogen Project. http://www.waterpathogens.org (A. Pruden, N. Ashbolt and J. Miller (eds) Part 3 Baceteria) http://www.waterpathogens.org/book/salmonella-enteric-fevers-salmonellosis Michigan State University, E. Lansing, MI, UNESCO. 3. Nosocomial and healthcare-associated NTM infections and their control. S Shakoor, M Owais, R Hasan, S Irfan. In: Non tuberculosis mycobacterium (NTM), 1st edition, Elsevier 2019. (https://www.elsevier.com/books/nontuberculous-mycobacteria-ntm/velayati/978-0-12-814692-7) 4. Nalin D, Hasan, R, Haque, S, and Boltonsky, H. Association between Malaria, Immunosuppression, and relatively high risk for diarrhoeal attacks. New prospects for Treatment and Prevention, Ed. by Holme, T., Holmegren, J., Merson, M.H., and Mollby R. Elsevier/North Holland Biomedical Press, (1981). (Impact Factor: NA) 5. Susceptibility testing of nontuberculous mycobacteria. I Ahmed, R Hasan, S Shakoor. In: Non tuberculosis mycobacterium (NTM), 1st edition, Elsevier 2019. (https://www.elsevier.com/books/nontuberculous-mycobacteria-ntm/velayati/978-0-12-814692-7) 6. Erum Khan, Rumina Hasan, Jaishri Mehraj and Sajid Mahmood. Genetic diversity of dengue viruses and associated clinical severity during periodic epidemics in South East Asia. In "Tropical Medicine", ISBN 978-953-307-877-9. EDITOR: Alfonso J. Rodriguez-Morales 2012 http://www.intechopen.com/articles/show/title/genetic-diversity-of-dengue-viruses-and- associated-clinical-severity-during-periodic-epidemics-in-so
CONTRIBUTIONS TO REPORTS, GUIDELINES AND POLICY DOCUMENTS: 01. Corticosteroids for COVID-19. Living Guidance (2 September 2020). WHO REFERENCE NUMBER: WHO/2019-nCoV/Corticosteroids/2020.1 https://www.who.int/publications/i/item/WHO-2019- nCoV-Corticosteroids-2020.1 02. Clinical management of COVID-19 Interim Guidance (27 May, 2020). WHO REFERENCE NUMBER: WHO/2019-nCoV/clinical/2020.5 https://www.who.int/publications/i/item/clinical-management- of-covid-19 03. WHO Consolidated Guidelines on Tuberculosis Module 3: Diagnosis. Rapid Diagnostics for Tuberculosis Detection. 2020; ISBN: 9789240007307 https://www.who.int/publications/i/item/who-consolidated-guidelines-on-tuberculosis-module-3- diagnosis---rapid-diagnostics-for-tuberculosis-detection 04. Rapid Communication: Molecular assays as initial tests for the diagnosis of tuberculosis and rifampicin resistance. January 2020. https://www.who.int/publications/i/item/9789240000339 05. Lateral flow urine lipoarabinomannan assay (LF-LAM) for the diagnosis of active tuberculosis in people living with HIV Policy update 2019. WHO/CDS/TB/2019.16. (https://www.who.int/tb/publications/2019/LAMPolicyUpdate2019/en/) 06. Global Antimicrobial Resistance Surveillance System (GLASS). WHO/WSI/AMR/2018.4. The detection and reporting of colistin resistance. https://apps.who.int/iris/bitstream/handle/10665/277175/WHO-WSI-AMR-2018.4-eng.pdf 07. Global Antimicrobial Resistance Surveillance System (GLASS). Early implementation 2017-2018. https://www.who.int/glass/resources/publications/early-implementation-report-2017-2018/en/ 08. Situation Analysis Report on Antimicrobial Resistance in Pakistan. Findings and Recommendations for Antibiotic Use and Resistance. 2018 https://cddep.org/publications/garp-pakistan-situation- analysis/ 09. Technical manual for drug susceptibility testing of medicines used in the treatment of tuberculosis. 2018 WHO. WHO/CDS/TB/2018.24 10. The Use of next-generation sequencing technologies for the detection of mutations associated with drug resistance in Mycobacterium tuberculosis complex: Technical Guide. 2018 WHO/ FIND. WHO/CDS/TB/2018.19. 11. National Laboratory Policy, Pakistan. December 2017. NIH Publication No. PHLD/NLWG-001-2018 12. National Laboratory Biosafety and Biosecurity Policy, Pakistan. December 2017. NIH Publication No. PHLD/NLWG-002-2018 13. National Strategic Framework for Containment of Antimicrobial Resistance (AMR). Ministry of National Health Services, Regulation and Coordination. Govt of Pakistan. 2017 14. GLI Guide to TB Specimen Referral Systems and Integrated Networks October 2017 http://www.stoptb.org/wg/gli/assets/documents/GLI_Guide_specimens_web_ready.pdf 15. GLI model TB diagnostic algorithms. March 2017 http://www.stoptb.org/wg/gli/assets/documents/GLI_algorithms.pdf 16. The use of molecular line probe assays for the detection of resistance to isoniazid and rifampicin. Policy Update WHO/HTM/TB/2016.12 https://apps.who.int/iris/handle/10665/250586 17. Framework of indicators and targets for laboratory strengthening under the End TB Strategy. WHO/HTM/TB/2016.18 18. The use of loop-mediated isothermal amplification (TB-LAMP) for the diagnosis of pulmonary tuberculosis: policy guidance. WHO/HTM/TB/2016.11 (https://www.who.int/tb/publications/lamp- diagnosis-molecular/en/) 19. National antimicrobial resistance surveillance systems and participation in the Global Antimicrobial Resistance Surveillance System (GLASS). A guide to planning, implementation, and monitoring and evaluation. WHO/DGO/AMR/2016.4 20. Diagnostic stewardship. A guide to implementation in antimicrobial resistance surveillance sites. WHO/DGO/AMR/2016.3 21. Guide for providing technical support to TB laboratories in low- and middle-income countries. A publication of the Global Laboratory Initiative (GLI), a working group of the Stop TB Partnership. 2015 http://www.stoptb.org/wg/GLI/documents.asp 22. The Use of Molecular Line Probe Assay for the Detection of Resistance to Second-Line Anti- Tuberculosis Drugs. WHO 2013. 23. The Use of a Commercial Loop-Mediated Isothermal Amplification Assay (TB-Lamp) for the Detection of Tuberculosis. WHO 2012. 24. Tuberculosis Laboratory Biosafety Manual. World Health Organisation 2012 25. National Guidelines for TB Infection Control. National TB Control Program, Ministry of Health, Pakistan. 2010 26. The Global Plan to STOP TB 2011-2015. STOP TB Partnership, WHO 2010. ISBN 978 92 4 150034 0 27. National Guidelines for the management of Drug Resistant Tuberculosis. National TB Control Program, Ministry of Health, Pakistan. 2009
RESEARCH GRANTS
As Principal Investigator 01. Comparative study of commercially available typhoid point of care tests to benchmark current and emerging tools. Foundation for Innovative New Diagnostics (FIND). (2020-2021). Amount US$ 96,591. PI: Rumina Hasan, Sadia Shakoor, Erum Khan, Farah Qamar 02. Strengthening Laboratory in Capacity for AMR surveillance. Health Security Partners (HSP). (2018- 2020). Amount US$ 250,179. PI: Rumina Hasan, Co-I: Zahra Hasan, Sadia Shakoor, Najia Ghanchi, Erum Khan, Joveria Farooqi, Kausar Jabeen, Afia Zafar, Imran Ahmed, Mohd. Zeeshan, Seema Irfan, Afia Zafar. 03. Technical assistance to support early implementation of Global Antimicrobial Surveillance System {GLASS) in laboratories in Pakistan. World Health Organisation (2017-2018) Amount: US$ 40,000. Collaborating Units: The Aga Khan University, Department of Microbiology, Sheikh Zayed Hospital Lahore, Allama Iqbal University, Lahore. PI: Rumina Hasan, Co-I: Sadia Shakoor. 04. How do policymaker perceptions of antimicrobial resistance drive behaviour and policies for appropriate antimicrobial use? A case study of Pakistan. Funded (March 2017- September 2018) (Aga Khan Univeristy, LSHTM, Royal Veterinary College). Total £245216 (AKU: £199,938). PI: Johanna Hanefeld, Co-I: Mishal Khan, Ana Mateus, Rumina Hasan (Pakistan PI). Economic and Social Research Council, UK 05. Bedaquiline External Quality Assessment (EQA) and Validation of Provisional Breakpoints. To validate reproducibility of BDQ breakpoints against M.tuberculosis. To establish epidemiological cutoff values (ECV/ECOFF) for BDQ and other select TB drugs. Janssen Pharmaceutical N.V. (2017-2018). Amount US$ 64,000 Collaborating Units: The Aga Khan University, Department of Microbiology and The National TB Reference Laboratory, Pakistan. PI: Rumina Hasan, Co-I: Sadia Shakoor, Joveria Farooqi, Dr. Sabira Tahseen. 06. Strengthening Laboratory Capacity for Antimicrobial Resistance Surveillance. Health Security Partners (HSP). (2016-2017). Amount US$ 80,000. PI: Rumina Hasan, Co-I: Erum Khan, Sadia Shakoor, Joveria Farooqi, Kausar Jabeen, Afia Zafar, Imran Ahmed, Mohd. Zeeshan, Seema Irfan, Afia Zafar 07. Bedaquiline Drug Resistance Emergence Assessment in Multidrug Resistant Tuberculosis (Bedaquiline DREAM Program) (2015-2019). Janssen Pharmaceutical N.V. Amount US$ 294,900 Collaborating Units: The Aga Khan University, Department of Microbiology and The National TB Reference Laboratory, Pakistan. PI: Rumina Hasan, Co-I: Sadia Shakoor, Joveria Farooqi. 08. Strengthening Laboratory Capacity for AMR surveillance. Health Security Partners (HSP). (2015-2016). Amount US$ 100,000. PI: Rumina Hasan, Co-I: Erum Khan, Sadia Shakoor, Joveria Farooqi. 09. Laboratory-strengthening to support surveillance for drug resistant tuberculosis in Pakistan. Funding for TB Supranational Reference Laboratory (SRL) Karachi. World Health Organization (2014-2015). Amount US$ 126,691. Collaborating Units: The Aga Khan University, Department of Microbiology, National TB Reference Laboratory, Pakistan and World Health Organisation Global TB Programme. PI: Rumina Hasan, Co-I: Sabira Tahseen, Joveria Farooqi, Sadia Shakoor. 10. Surveillance of resistance to fluoroquinolones and pyrazinamide among M.tuberculosis isolates from Pakistan. World Health Organization (2013-2014). Amount US$ 178,883. Collaborating Units: The Aga Khan University, Department of Microbiology, National TB Reference Laboratory, Pakistan and World Health Organisation Global TB Programme. PI: Rumina Hasan, Co-I: Sabira Tahseen, Joveria Farooqi, Sadia Shakoor. 11. Prevalence of Mycobacterium tuberculosis strains in Karachi and their association with drug resistance. Bennendon Society (2006-2010). Amount £ 40,100. Collaborating Units: The Aga Khan University, Department of Microbiology and Marie Adelaide Leprosy Centre, Karachi. PI: Rumina Hasan, Co-I: Zahra Hasan 12. Antimicrobial resistance in Pakistan; A program to develop and strengthen capacity for surveillance, containment and diagnosis through public-private sector partnership. USAID-S&T (2006-2010). Amount US$ 575,000. Collaborating Units: The Aga Khan University, Department of Microbiology, Marie Adelaide Leprosy Centre, Karachi. Pakistan Medical Research Council, National Institute of Health, Pakistan. Centres for Disease Control and Prevention, Atlanta USA. Pakistan PI: Rumina Hasan, Co-I: Afia Zafar, Anita Zaidi, Rabia Hussain, Zahra Hasan, Amna Rehana Siddiqui, Anwar Siddiqui, Huma Qureshi, Saeeda Haider, Safia Siddiqui, Altaf Ahmed. US PI: Mary Brandt 13. Characterization of M.tuberculosis Beijing strains in Pakistan using molecular and immunological techniques: AKU URC (2003-2006). Amount US$ 36250. Collaborating Units: The Aga Khan University, Department of Microbiology and Marie Adelaide Leprosy Centre, Karachi. PI: Dr. Rumina Hasan Co-I: Dr. Rabia Hussain & Dr. Zahra Hasan 14. Evaluation of Bacteriophage assay for diagnosis of M.tuberculosis infection. BIOTEC (2001-2002). Amount Rs. 300,000 PI: Rumina Hasan Co-I: Rabia Hussain 15. Nosocomial Organisms; Prevalence and Resistance in Acute and Intensive Care Units at Aku. Funded: Merck, Sharp and Dhome Co. ltd. (1997). Amount Rs. 54,500 and reagents for one year. PI: Rumina Hasan 16. Synercid (quinupristin and dalfopristin) efficacy for Methicillin Resistant Staphylococcus aureus: In-Vitro Study. Rhone-Poulenc Rorer (1997). Amount Rs. 88,500 and reagents for one year. Collaborating Units: The Aga Khan University, Departments of Microbiology and Medicine. PI: Rumina Hasan Co-I: Bushra Jamil. 17. Response of Macrophages and Poly-morphonuclear cells to antigens and antibodies in leprosy. AKU (1986 - 1988) Amount $ 7,000 for two years. Collaborating Units: The Aga Khan University, Department of Microbiology, Marie Adelaide Leprosy Centre, Karachi and London School of Hygiene and Tropical Medicine PI: Rumina Hasan, Co-I: Rabia Hussain, Thomas Chiang, Hazel Dockrell. 18. Seroepidemiology of leprosy: To study role of antibodies in the pathogenesis of leprosy. Funded: The Director's Initiative Fund; World Health Organization TDR Programme (1985) Amount: $ 15,000 for one year. Collaborating Units: The Aga Khan University, Department of Microbiology, Marie Adelaide Leprosy Centre, Karachi and London School of Hygiene and Tropical Medicine. PI: Rumina Hasan, Co- I: Rabia Hussain, Hazel Dockrell.
As Co-Investigator 01. Exploring the transcriptomics of Bedaquiline resistant M. tuberculosis isolates. University Research Council AKU (2019-2021) Rs. 2,983,050. PI: Dania Saeed. Co-I: Rumina Hasan, Zahra Hasan, Sadia Shakoor. 02. Burden of Antimicrobial Resistance as part of Global Research on Antimicrobial Resistance (GRAM) and Global Burden of Disease (GBD). Funded Dept Health UK (through University of Oxford) (January to June 2020) £12,972 PI: Sadia Shakoor, Co-I: Rumina Hasan, Mohammad Zeeshan, GRAM-GBD group 03. Fleming Fund Country Grant (II) to strengthen national capacity for detection and surveillance of antimicrobial resistant organisms in Pakistan. UK Dept of Health and Social Care Funded (2020- 2021). Pakistan PI: Erum Khan, Co-I: Rumina Hasan, Sadia Shakoor. 04. Phylo- and immuno- dynamics of SARS-CoV-2 infection in Pakistan: relating COVID 19 disease severity in with viral diversity. Funded HEC (2020-2023). Rs. 12,253,463. PI Zahra Hasan, CoI: Rumina Hasan, Kiran Iqbal, Najia Ghanchi, Asghar Nasir, Kiren Habib, Iffat Khanum, Nosheen Nasir, Syed Hani Abidi, Faisal Mahmood, MB Raja Dharejo. 05. Addressing conflict of interest driving irrational prescribing of antibiotics in pluralistic health systems: an interventional study in Pakistan. Funded HSRI/MRC (2020-2021). Total Budget £617,523 (AKU £218,725). PI Mishal Khan, Helena Legido-Quigley. Pakistan PI: Sadia Shakoor, Co-I: Rumina Hasan, Sameen Siddiqui, Wafa Aftab, Rehana Siddiqui, Johannna Hanefeld. 06. Fleming Fund Country Grant (I) to strengthen national capacity for detection and surveillance of antimicrobial resistant organisms in Pakistan. UK Dept of Health and Social Care Funded (2019- 2021). Pakistan PI: Erum Khan, Co-I: Rumina Hasan, Sadia Shakoor, Rehana Siddiqui, Afia Zafar, Sameen Siddiqi. 07. Novel inter-disciplinary approaches for identifying and tackling the spread of Antimicrobial Resistance through Environmental pathways in Pakistan Funded (October 2017- March 2018). £80,000 PI Chris Quince/Sadia Shakoor, Co-I: Rumina Hasan, Elizabeth Wellington. 08. Characterization of human immunodeficiency virus (HIV)-1 among newly diagnosed treatment- naive Pakistani patients. Blood Systems Research Institute. Funded (Aug 2015-Aug 2016). US$ 25,000 The Aga Khan University Department of Microbiology, Bridge Foundation, Duke University Medical Centre US and Blood Systems Research Institute, San Francisco, California. PI: Zahra Hasan, Co-I: Rumina Hasan, Sharaf Ali Shah et al…. 09. Assessment of microbial water quality and antibiotic resistance in potable water in two peri-urban slums of Rehri Goth and Bhains Colony, Karachi. International Foundation for Science. Funded 2015- 2016. US$ 11,900 The Aga Khan University Departments of Microbiology and Paediatrics PI: Sadia Shakoor, Co-I: Rumina Hasan, Anita Zaidi 10. Pathogen Surveillance, Outbreak Response, Biosafety and Biosecurity Capacity Development in Pakistan. Funding agency: NIH (September 2014 – September 2016) Amount: US$ 239879. Collaborating Units: The Aga Khan University Departments of Microbiology and Paediatrics. PI: Sadia Shakoor, Co-I: Rumina Hasan 11. The Role of Arboviruses as a Cause of Undifferentiated Febrile Illness in Sindh Pakistan. Defence Threats Reduction Agency (DTRA). Funded 2014-2017 (US $515,350.00) Collaborating Units: The Aga Khan University Department of Microbiology and University of Florida PI: Erum Khan, Co-I: Rumina Hasan, Joveria Farooqi et al 12. Improving diagnosis of pulmonary TB in children using stool specimens as alternative to gastric aspirates using Xpert MTB/RIF assay in a high burden setting. (Funded 2014-2015) $ 5742. EMRO/TDR Small Grants Scheme, World Health Organization. PI: Zahra Hasan, Co-I: Rumina Hasan, Sadia Shakoor, Fehmina Arif, Aisha Mehnaz 13. Evaluation of Sensitivity and Specificity of GenoType MTB DRplus Line Probe Assay in Rapid Diagnosis of Tuberculous Pleural Effusion. URC (Funded 2013-2015) Amount PKR: 2,418.208 (US$23,000) Collaborating Units: The Aga Khan University Departments of Microbiology and Medicine. PI: Mohd Irfan, Co-I: Rumina Hasan, Kausar Jabeen 14. Evaluation of sensitivity and specificity, rapidity and cost of broth micro-colony detection method for microbiological monitoring of multi-resistant tuberculosis treatment. URC (Funded 2012-2014) Amount PKR: 2225,940 (US$25,000). Collaborating Unit: The Aga Khan University Departments of Microbiology PI: Seema Irfan, Co-I: Rumina Hasan, Kausar Jabeen. 15. Fluoroquinolone resistance; role of gene mutations and efflux pump among clinical isolates of Mycobacterium tuberculosis”AKU seed money (2012-2014). Amount: US$12,357 Collaborating Unit: The Aga Khan University Department of Microbiology PI: Asho Ali, Co-I: Zahra Hasan, Rumina Hasan 16. Prevalence, species distribution, and trends in resistance of fungi responsible for invasive mycoses in Pakistan, USAID-HEC 2010-2013 (approved) US$ 234,000. Collaborating Unit: The Aga Khan University Department of Microbiology PI: Afia Zafar, Co-I: Rumina Hasan, Kauser Jabeen, Rasheeda Ahmed, Rehana Siddiqui, Faisal Mahmood, Usman Shaikh 17. Characterization of drug resistant mutations in externsively drug resistant M.tuberculosis (MTB) strains prevalent in Pakistan – development of rapid assays for screening MTB isolates, TDR WHO 2009-2010 (approved) US$ 10,000. Collaborating Unit: The Aga Khan University Department of Microbiology. PI: Zahra Hasan, Co-I: Rumina Hasan, Asho Ali 18. Molecular epidemiology and deletion analysis of Mycobacterium tuberculosis strains associated with pulmonary and extra pulmonary tuberculosis (PhD student). URC (Funded 2008-2010) US$14,500. PI: Akbar Kanji, Supervisors: Rumina Hasan, Zahra Hasan 19. Assessment of impact of Hib vaccine in preventing pneumonia and bacterial meningitis in children in Pakistan. Hib Initiative, GAVI 2008-2011. Collaborating Units: The Aga Khan University Departments of Microbiology and Pediatrics PI: Anita Zaidi: Co-I: Rumina Hasan et al. 20. Diarrhea in infants and children in developing countries: case-control study. Gates Enteric Multi- center Study with the Center for Vaccine Development, University of Maryland, Baltimore. Gates Foundation. 2007-2010. Collaborating Units: The Aga Khan University Departments of Microbiology and Pediatrics PI: Anita Zaidi: Co-I: Rumina Hasan et al. 21. Infectious Diseases and Child Health in Pakistan. NIH, USA Fogarty Training Grant (2006-2011). Focus on training in vaccinology and neonatal infectious disease research. Collaborating Units: The Aga Khan University Departments of Microbiology and Pediatrics PI: Anita Zaidi: Co-I: Rumina Hasan et al. 22. National burden estimate of rotavirus gastroenteritis in Pakistan. WHO and Rotavirus vaccine program (2006-2008)? Collaborating Units: The Aga Khan University Departments of Microbiology and Pediatrics PI: Anita Zaidi: Co-I: Rumina Hasan et al. 23. Population-based surveillance for major pneumococcal syndromes in a rural community of Sindh, Pakistan. PneumoADIP 2006-2007. $80,000. Collaborating Units: The Aga Khan University Departments of Microbiology and Paediatrics. PI: Anita Zaidi: Co-I: Rumina Hasan et al. 24. Burden of rotavirus infection in Pakistani children. Rotavirus Vaccine Program and Program for Appropriate Technology in Health. 2005-2007. Collaborating Units: The Aga Khan University Departments of Microbiology and Paediatrics PI: Anita Zaidi: Co-I: Rumina Hasan et al. 25. Enhanced Surveillance of Invasive Pneumococcal Disease (Funded 2005-2006 PneumoADIP) Amount US $ 30,000. Collaborating Units: The Aga Khan University Departments of Microbiology and Paediatrics. PI: Anita Zaidi: Co-I: Rumina Hasan et al. 26. Chemokines as immunopathological markers in tuberculosis infections – pulmonary and extra- pulmonary $ 70,100 PI: Dr. Zahra Hasan, Co-PI Dr. Rabia Hussain and Dr. Rumina Hasan World Health Organization. (June 2004) 27. Association of genetic diversity with virulence and antimicrobial resistance in M. tuberculosis isolates at The Aga Khan University Hospital, (PhD Student). URC (Funded 2004-2008) Amount US$ 34000 PI: Asho Ali, Supervisors: Rumina Hasan, Zahra Hasan 28. Optimal detection of Salmonella enteric serotypes Typhi and Paratyphi in blood of children in Pakistan. The American Society of Tropical Medicine and Hygiene (Funded 2004-2005). Amount US$ 75,000. Collaborating Units: The Aga Khan University Departments of Microbiology and Paediatrics. PI: Anita Zaidi: Co-I: Rumina Hasan et al 29. WHO Multicenter Study of Clinical Signs Predicting Serious Illness (Funded 2003-2004, WHO and Saving Newborn Lives). Collaborating Units: The Aga Khan University Departments of Microbiology and Paediatrics. 30. Burden of Haemophilus influenzae type b disease in Pakistani children. Surveillance of Hib meningitis in Sindh (in collaboration with WHO and Federal EPI Programme. Funded WHO (2003) PI: Anita Zaidi: Co-I: Rumina Hasan et al 31. Efficacy of a combined Vi vaccination and health education program on reducing the burden of typhoid during childhood: a demonstration project in Karachi, Pakistan. Funded IVI DOMI (2001) Collaborating Units: The Aga Khan University Departments of Microbiology and Paediatrics. PI: Zulfiqar Bhutta: Co-I: Rumina Hasan, Afia Zafar et al 32. An estimation of the burden of cholera and shigella diarrhea and related mortality in urban and a rural area of Sindh, Pakistan. Funded IVI DOMI (2001) Collaborating Units: The Aga Khan University Departments of Microbiology and Pediatrics. PI: Zulfiqar Bhutta: Co-I: Rumina Hasan, Afia Zafar et al 33. Genotypic characterisation of Salmonella enteric serotypes Typhi and Paratyphi from Karachi. Funded URC, AKU. (2001) PI: Anita Zaidi, Co-I: Rumina Hasan 34. Viral etiology of acute aseptic meningitis at AKUH. Funded: AKU seed money grant (2001-2002) Amount US$ 10000 35. An evaluation of the burden and spectrum of respiratory bacterial pathogens in children under five years of age in a community setting in Karachi Pakistan; implication for prevention and therapy. Funded: University Research Council (2001-2004). Amount: US$ 31000. Collaborating Units: The Aga Khan University Departments of Microbiology and Pediatrics. PI: S.Q.Nizami, Co-I: Z. Bhutta, R. Hasan, Y.A. Husen 36. Prevalence and predictors of pulmonary tuberculosis and treatment outcome under DOTS in a low- income neighbourhood, Karachi. Funded: University Research Council (2001-2004). Amount: US$ 33540. Collaborating Units: The Aga Khan University Departments of Microbiology and Community Health Science. PI: Saeed Akhtar, Co-I: Rumina Hasan 37. Extent and factors associated with endemic level of Crimean Congo haemorrhagic fever virus infection in endemic areas Funded: University Research Council (2001-2004). Amount: US$ 15000. Collaborating Units: The Aga Khan University Departments of Microbiology and Community Health Sciences. PI: Saeed Akhtar, Co-I: Rumina Hasan 38. Prevalence of Rota virus Diarrhoea in the Community. Funded: Proctor and Gamble (2000-2001). Amount: Rs. 280,000 for one year. Collaborating Units: The Aga Khan University Hospital, Clinical Laboratory and Department of Community Health Sciences. 39. A Prospective study to assess the Relationship between Antibiotic Usage and the Emergence of Antibiotic Resistance in an Intensive Care Unit. Funded: AKU seed money funding (1998). Amount: $ 2650 for one year. Collaborating Units: The Aga Khan University Hospital, Clinical Laboratory, Pharmacy and Department of Medicine. PI: Arif Sarwari, Co-I: Rumina Hasan, Shamim Raza 40. Management of Pulmonary Tuberculosis through a low-cost facility. Funded: AKU seed money funding (1998). Amount: $ 8000 for one year. Collaborating Units: The Aga Khan University Hospital, Clinical Laboratory and Department of Community Health Sciences. PI: Amna Rehana Siddiqui, Co-I: Rumina Hasan 41. Treatment and Hand Washing in Karachi, Pakistan. Funded: Proctor and Gamble (1997-1998). Amount: Rs. 116,000 and equipment for one year. Collaborating Units: The Aga Khan University Hospital, Clinical Laboratory and Department of Community Health Sciences. PI: Steve Luby, Co-I Rumina Hasan, M.Agboatwalla, A.Raza, E.Mintz, J.Sobel, S.Hussain, R.Husan, F.Ghouri, K.Baier, G.Gangarosa. 42. Microbiological Evaluation and Community Acceptance of a Plastic Water Storage Vessel with Point-of- Use Water Immunological Evaluation of Purified Recombinant and Synthetic M.leprae antigens. WHO, TDR Programme Based Grant (1989-1992) Amount: US$ 227,358 Collaborating Units: London School of Hygiene and Tropical Medicine; Aga Khan University, Department of Microbiology and Marie Adelaide Leprosy Centre, Karachi, PI: Dr. Rabia Hussain, Co PI: Dr. Rumina Hasan, Dr. Hazel Dockrell. 43. Molecular Markers for prediction of reactions in leprosy. Rockefeller Foundation Grant, Neglected Disease Programme (1987-1990) Amount: $ 120,000 for three years. Collaborating Units: London School of Hygiene and Tropical Medicine; Aga Khan University, Department of Microbiology.